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1. INTRODUCTION 
1.1 INTRODUCTION TO ANALYTICAL CHEMISTRY 
        (http://www.files.chem.vt.edu/chem-ed/crossref/ac-intro.html) 
Analytical chemistry is the science of making quantitative measurements. In 
practice, quantifying analytes in a complex sample becomes an exercise in problem 
solving. To be effective and efficient, analyzing samples requires expertise in: 
1. the chemistry that can occur in a sample 
2. analysis and sample handling methods for a wide variety of problems (the 
tools-of-the-trade) 
3. proper data analysis and record keeping 
To meet these needs, Analytical Chemistry courses usually emphasize 
equilibrium, spectroscopic and electrochemical analysis, separations, and 
statistics. Analytical chemistry requires a broad background knowledge of 
chemical and physical concepts. These hypermedia documents contain links to the 
fundamental principles that underly the different analytical methods. With a 
fundamental understanding of analytical methods, a scientist faced with a difficult 
analytical problem can apply the most appropriate technique(s). A fundamental 
understanding also makes it easier to identify when a particular problem cannot be 
solved by traditional methods, and gives an analyst the knowledge that is needed 
to develop creative approaches or new analytical methods. 
The methods of detecting analytes are the fallowing 
1. Physical means 
o mass 
o colour 
o refractive index 
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o thermal conductivity 
2. With electromagnetic radiation (Spectroscopy) 
o Absorption 
o Emission 
o Scattering 
3. By an electric charge 
o Electrochemistry 
o Mass spectrometry 
Thereare a limited number of ways to detect an analyte. However, in each of 
the above general categories there are a large multitude of specific analytical 
techniques. 
1.1.1 Importance Of Analysis (Kellner et al., 2004) 
Newer analytical methods are developed for the drugs or drug combinations due 
to the patient must receive the good quality of drugs, the drug or drug combinations 
may not be official in any Pharmacopoeia, a literature search may not reveal an 
analytical procedure for the drug or it combinations, analytical methods may not be 
available for the drug combinations due to interference caused by excipients and 
analytical methods for the quantification of drug or drug combinations from 
biological fluids may not be available. 
The  development of newer analytical methods are very importance in many of the 
fields like research institutions, quality control department in industries, approved 
testing laboratories, biopharmaceutical and bio equivalence study and clinical 
pharmacokinetic studies. 
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1.1.2 Disciplines Of Analytical Chemistry  
(Gurdeep R. Chatwal et al., 2007; Napoleon, 2006; Kamboj, 2007)                                                      
There are two types of analysis. Those are as follows: 
a) Qualitative analysis 
b) Quantitative analysis 
1.1.2.1 Qualitative analysis 
This is practiced in order to establish the composition of naturally occur 
artificially synthesized or manufactured substances. 
 1.1.2.2 Quantitative analysis 
There are several methods for quantitative analysis such methods are as 
mentioned below. 
 1.1.2.2.1 Chemical methods 
1.1.2.2.1.1 Titrimetric analysis 
The titrimetric methods are considered superior to gravimetric methods the 
analysis is similarly based on equivalent weight of one substance reacts quantitatively 
with the other. 
i. Acid-base titrations 
ii. Non-aqueous titrations 
iii. Redox titrations 
iv. Precipitation titrations 
v. Complexometric titrations 
1.1.2.2.1.2 Gravimetric analysis 
The method involves the conversion of the element or a radical to be 
determined into a pure stable compound, readily convertible into a form suitable for 
weighing. 
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1.1.2.2.1.3 Gasometric analysis 
 The gases like cyclopropane, carbon dioxide, nitrous oxide, oxygen, octyl 
nitrate, nitrogen, amyl nitrate, ethylene and helium are determined by gasometric 
analysis. The measurement of volume of gas is usually done by means of gas burettes.  
1.1.2.2.2 Physicochemical methods 
These methods are mainly used for the measurement of certain physical 
properties and to determine the contents or composition of a substance. They are 
employed for the determination of trace concentrations of elements in preference to 
the sample. These are preferred due to their selectivity, simplicity, speed of analysis 
and accuracy than other methods. Most of the methods make use of standards having 
in the known amount of the constituents serves as the basis of comparison in the 
instrument. The changes in the properties of system detected by measurement of 
current, potential, electrical conductivity, specific rotation and refractive index. 
 1.1.2.2.3 Microbiological methods 
Many microorganisms produce within themselves in chemical substances, 
which when excreted, interfere with the growth or metabolism of microorganisms. 
Such compounds are known as antibiotics and need to be present in low 
concentrations to bring out the antibiotic action. Antibiotics are chemotherapeutic 
agents. In micro biological methods comparison of the inhibition of the growth of the 
bacteria by a measured concentration of antibiotic which is to be examined is 
compared with the known concentration of the antibiotic standard preparation having   
known activity. Widely used methods are cup plate method and tube assay method. 
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1.1.2.2.4 Biological methods 
When the potency of the drug or its derivative cannot be properly determined 
by physical or chemical methods, and where it is possible to observe the biological 
effects of the drug on some type of living matter, the biological assays are carried out 
on the basis of such assays is to determine how much of sample gives the same 
biological effect as a given quantity of the standard preparation. The sample and 
standard tested under identical conditions in all respect. In a typical bio-assay, a 
stimulus is applied to a subject. The intensity of stimulus applied to a subject is 
referred to as the dose and is indicated by a weight or in terms of the concentration of 
the preparation. The application of a stimulus on a subject produces some observable 
effect and this is called the response. The response may be measured by the total 
weight or weight of some organ of the subject, blood sugar concentration, and 
diameter of inhibition zone or by some other physiological symptoms. 
1.2 SPECTROSCOPY(http://www.wavesignal.com/forensics/Anlys.html) 
 Spectroscopy is the study of matter and its properties by investigating light, 
sound, or particles that are emitted, absorbed or scattered by the matter under 
investigation. Spectroscopy may also be defined as the study of the interaction 
between light and matter. Historically, spectroscopy referred to a branch of science in 
which visible light was used for theoretical studies on the structure of matter and for 
qualitative and quantitative analyses. The definition has broadened, however, as new 
techniques have been developed that utilize not only visible light, but many other 
forms of electromagnetic and non-electromagnetic radiation including x-rays, 
microwaves, radio waves, electrons, phonons (sound waves) and others. Impedance 
spectroscopy is a study of frequency response in alternating current. Spectroscopy is 
often used for the identification of substances through the frequency spectrum emitted 
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or absorbed by them. A device for recording a spectrum is a spectrometer. 
Spectroscopy can be classified according to the physical quantity which is measured 
or calculated or the measurement process. 
1.2.1 Spectroscopic Methods 
(Gurudeep R. Chatwal, et al., 2008; Beckett and Stenlake, et al., 2007) 
Spectroscopy deals with the interaction of an analyte with electromagnetic 
radiation. The interaction of the electromagnetic radiation results in absorption or 
emission radiations. Based on the absorption or emission the spectroscopy is 
classified into, absorption spectroscopy and emission spectroscopy. 
1.2.1.1 Absorption spectroscopy 
When a beam of electromagnetic radiation is passed through an analyte, 
certain amount of the radiation is absorbed into the matter. The analyte after 
absorbing the radiation goes from the ground state to the excited state giving the 
absorption spectra. The various absorption spectroscopies include the UV-Visible 
absorption,X-ray absorption, infrared absorption, microwave absorption, radio 
frequency absorption and atomic absorption, etc. 
1.2.1.1.1 Atomic Absorption 
In the atomic absorption spectra the electrons are excited from the lower 
energy state to a higher energy state by absorption of electromagnetic radiation. The 
atom absorbs the electromagnetic radiation of energy corresponding to the difference 
in energy between the higher and lower energy states of the absorbing atom. UV-
Visible radiation can excite only the electrons in the outer most orbital, whereas the 
X-ray has the capacity to excite the electrons located in the inner shell near to the 
nuclei. 
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 1.2.1.1.2 Molecular Absorption 
The molecular absorption spectra of polyatomic molecules are more complex 
than the atomic absorption spectra since the number of energy states are higher. The 
energies associated with a molecule are rotational energy, vibrational energy and 
electronic energy.  
   E = Eelectronic + Evibrational +Erotational 
The molecule absorbs electromagnetic radiation of energy corresponding to the 
difference in the energy of the ground state molecule and the excited state molecule. 
The difference in energy ∆E is given by, 
∆E = (Eelectronic + Evibrational +Erotational) excited – (Eelectronic + Evibrational +Erotational) ground 
The UV-Visible radiations and X-rays have the energy to induce the transition from 
the ground state to the excited state. 
1.2.1.2 Emission spectroscopy 
Emission spectroscopy is the technique in which the wavelength of the 
photons emitted by an analyte due to the transition from higher energy level to lower 
energy on exposure to an electromagnetic radiation was studied. Each analyte emits a 
specific wavelength of radiation corresponding to the composition of the sample. The 
energy of the photons emitted is given by 
    Ephoton= hυ 
Where E is the energy of the photon, ν is the frequency and h is the Planck’s 
constant. The various instrumental techniques which are based on the measurement of 
the emitted radiation include Flame photometry, Fluorimetry, Radiochemical 
methods. 
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1.2.1.2.1 Atomic Emission 
When an analyte is heated, it emits light characteristic of the atom present in 
it. For example, Sodium when heated emits yellow light and Potassium emits lilac 
light. When a metal is heated, the electrons in the outer orbital absorb the heat and 
goes to a higher energy state. The atom then comes back to the ground state by 
emitting the photons of light which has energy equal to the difference between the 
higher energy state and the lower energy state. The instrumental analytical technique, 
such as the flame emission spectroscopy works on the principle of measuring the 
photons of energy emitted by a thermally excited atom. 
1.2.1.2.2 Molecular Emission 
When a beam of electromagnetic radiation falls on a molecular species, it 
absorbs the radiation and gets excited. The excited molecules are short lived and it fall 
back to the ground state immediately. The molecules in the excited sate have higher 
vibrational energy than that of the ground state. They emit the absorbed energy by the 
following ways, fluorescence and phosphorescence. 
The difference in the energy levels of the absorbed radiation, fluorescence and 
phosphorescence are as below 
∆Eabsorption> ∆Efluorescence> ∆Ephosphorescence 
The analytical techniques Spectrofluorimetry and Phosphorimetry involve the 
principle of molecular emission. 
1.2.2 Ultraviolet Spectroscopy   (Beckett and Stenlake, 2002)  
This technique of ultra violet spectroscopy is one of most frequently employed 
method in pharmaceutical analysis. It involves the measurement of the amount of UV 
radiation (190 - 380 nm) or visible (380 - 800 nm) radiation absorbed by a substance in 
solution. Ultraviolet spectroscopy involves the promotion of electrons (σ, π, n electrons) 
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from the ground state to higher energy state. It is useful to measure the number of 
conjugated double bonds and also aromatic conjugation with the various molecules. 
 The ultraviolet region of the electromagnetic spectrum is frequently 
subdivided into as follows: 
 Far vacuum Ultraviolet region (10 - 200 nm) 
 Near Ultraviolet region (200 - 400 nm) 
 Visible region (380 - 780 nm) 
Ultra violet absorption spectra are attributed to a process in which the outer 
electron of atoms or molecules absorbs radiant energy and undergoes transitions to 
higher energy level. Their transitions arequantitized and depend on electronic 
structure of the absorbent. Many molecules absorb ultraviolet or visible light. The 
absorbance of a solution increases as attenuation of the beam increases. Absorbance is 
directly proportional to the path length, b, and the concentration, c, of the absorbing 
species. Beer's Law states that   
 A = bc,  
Where,  
 Is a constant of proportionality, called the absorptivity. 
 Different molecules absorb radiation of different wavelengths. An absorption 
spectrum will show a number of absorption bands corresponding to structural groups 
within the molecule.  
 1.2.2.1 Beer - Lambert’s Law  
 (B.K Sharma, 2006; Robert D. Braun et al., 2006; Gurudeep R. Chatwal et al, 2008) 
 When light is incident upon a homogeneous medium, a part of incident light is 
reflected, a part is absorbed by the medium and the remainder is allowed to transmit 
as such. 
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I0 = Ia + It + Ir 
 Where,   
  I0 = Incident light 
  Ia = Absorbed light 
  It = Transmitted light 
  Ir = Reflected light 
Lambert’s Law states “when a beam of light is allowed to pass through a transparent 
medium, the rate of decrease of intensity with the thickness of the medium is directly 
proportional to the intensity of the light”. 
- 
  
  
   
  It = I0 e
-kt
---------- (1) 
 
Beer’s Law states “The intensity of a beam of monochromatic light decreases 
exponentially with the increase in concentration of the absorbing substance”. 
     - 
  
  
   
It = I0 e
-k’c----------- (2) 
(or) 
  
  
  
      
By solving equations 1 and 2, on changing equations from natural logarithm, 
   It = I0. 10
-0.4343kt
 = I0 10
-kt
----------- (3) 
   It = I0. 10
-0.4343 k’c
 = I0
-k’c       
----------- (4) 
On combining equations 3 and 4, 
It = I0 10
-act
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Where k and k' are constants, C is the concentration of the absorbing substance and         
t denotes thickness of the medium. 
1.2.2.1.1 Limitations of Beer’s law 
 The linearity of the Beer-Lambert law is limited by chemical and instrumental 
factors. Causes of nonlinearity include:  
 Deviations in absorptivity coefficients at high concentrations (>0.01M) due to 
electrostatic interactions between molecules in close proximity.  
 Scattering of light due to particulates in the sample.  
 Fluorescence or phosphorescence of the sample.  
 Changes in refractive index at high analyte concentration.  
 Shifts in chemical equilibrium as a function of concentration.  
 Non-monochromatic radiation, deviations can be minimized by using a 
relatively flat part of the absorption spectrum such as the maximum of an 
absorption band.  
 Stray light.  
1.2.2.1.2 Deviations from Beer’s law 
 According to Beer’s law, a straight line passing through the origin should be 
obtained, when a graph is plotted between absorbance and concentration. But there is 
always a deviation from linear relationship between absorbance and concentration and 
intact the shape of an absorption curve usually changes with changes in concentration 
of solution and unless precautions are observed. Deviations from the law may be 
positive or negative according to whether the resulting curve is concave upward or 
concave downward. 
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The latter two are generally known as instrumental deviation and chemical deviation. 
a. Instrumental deviations 
 Stray radiation, Improper slit width, Fluctuation in single beam. 
b. Chemical deviations 
 Hydrolysis, Association, Polymerization, Ionization and Hydrogen bonding 
Deviations from Beer’s law can arise due to the following factors 
1. Beer’s law will hold over a wide range of concentration provided the 
structure of coloured ion or of the coloured non electrolyte in the 
dissolved state does not change with concentration. If a coloured solution 
is having a foreign substance whose ions do not react chemically with the 
coloured components, its small concentration does not affect the light 
absorption and may also alter the value of extinction co - efficient. 
2. Deviations may also occur if the coloured solute ions dissociates or 
associates. 
3. Deviations may also occur due to the presence of impurities that 
fluorescence or absorb at absorption wavelength. 
4. Deviations may occur if monochromatic light is not used. 
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5. Deviations may occur if the width of slit is not proper and therefore it 
allows undesirable radiations to fall on the detector. 
6. Deviations may occur if the solution undergoes polymerization. 
7. Beer’s law cannot apply to suspensions but the latter can estimated 
calorimetrically after preparing a reference curve with known 
concentrations. 
1.2.2.2 Choice of solvent (William Kemp, 2006) 
 A suitable solvent for ultraviolet spectroscopy should meet the following 
requirements. 
(i) It should not itself absorb radiations in the region under investigation. 
(ii) It should be less Polar so that it has minimum interaction with the solute molecule. 
Solvents used in UV spectroscopy. 
S.No. Solvent Cut-off  (nm) 
1. Ethanol 205 
2. Methanol 210 
3. Acetonitrile 210 
4. Hexane 210 
5. Cyclohexane 210 
6. Diethyl ether 220 
7. Chloroform 245 
8. Carbon tetrachloride 265 
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1.2.2.3 Transitions in organic molecules  
(Sharma Y.R, et al., 2009; Gurdeep R. Chatwal, et al., 2008) 
The absorption in the ultraviolet region results in the transition of the valence 
electron form the ground level to the excited level. The three types of electron 
transitions are 
Sigma (σ) electrons: These are involved in the formation of saturated bonds. The 
energy required for the excitation of the electrons is more than that of the UV 
radiations. Hence these electrons do not absorb near UV radiation. 
Pi (π) electrons: These are involved in the formation of unsaturated bonds. 
Example: Dienes, trienes and aromatic compounds. It absorbs radiation in near UV 
region. 
Nonbonding (n) electrons: These are the lone pair of electrons present in atoms such 
as oxygen, nitrogen etc., in a molecule. They can be excited by both UV and Visible 
radiations. 
The various types of transitions are 
σ →σ* 
n→σ* 
π → π * 
 n→π* 
 
(http://teaching.shu.ac.uk/hwb/chemistry/tutorials/molspec/uvvisab1.html) 
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(http://www.pharmatutor.org/pharma-analysis/analytical-aspects-of-uv-visible-
spectroscopy/types-of-electrone-transition.html) 
The energy required for the various types of transitions are  
σ→σ* >n→σ* >π → π * > n→ π *  
σ→σ* transitions 
These transitions occur in saturated hydrocarbons with single bonds and no 
lone pair of electrons. The energy required for this type of transition is very high 
because of the strong sigma bond formed by the valence electrons. Thus, the 
transitions occur at very short wavelength. The saturated hydrocarbons such as 
methane, ethane, propane etc. absorbs at 126 -135 nm region of the UV region. Hence 
these compounds are used as solvents in UV spectroscopy. 
n → σ* transitions 
Saturated compounds with lone pair of electrons show n→σ* transitions in 
addition to σ→σ* transitions. The energy required for the n→σ* transition is lesser 
than the energy required for σ→σ* transitions. The energy required for n→σ* 
transition, in alkyl halides, decreases with increase in the size of the halogen atom. 
Alcohols and amines forms hydrogen bonding with the solvent hence require higher 
energy for the transitions. 
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π → π * transitions 
These transitions occur in unsaturated compounds containing double or triple 
bonds and also in aromatic compounds. Lower energy is required for these transitions 
and hence a longer wavelength causes the excitation of the molecule. 
n→ π* transitions 
These transitions occur in compound which contains oxygen, nitrogen, sulphur 
and halogens because of the presence of free lone pair of electrons. These transitions 
require least amount of energy and hence they occur in UV and Visible region. 
Saturated carbonyl compounds shows two types of transitions, low energy n→ π* 
transitions occurring at longer wavelength and high energy n→ π* transitions 
occurring at lower wavelength. The shifts in the absorption of the carbonyl 
compounds are due to the polarity of the solvent. 
1.2.2.4 Instrumentation(Gurudeep R. Chatwal et al., 2008) 
(http://www2.chemistry.msu.edu/faculty/reusch/virtTxtJml/Spectrpy/UVVis/uvspec. 
html) 
 All photometers, colorimeters and spectrophotometers have the following 
basic components 
1.2.2.4.1 Radiation source  
i) It must be stable. 
ii) It must be of sufficient intensity for the transmitted energy to be detected at  
the end of the optical path. 
iii) It must supply continuous radiation over the entire wavelength region in 
which it is used. 
UV region  
 Hydrogen discharge lamp, Deuterium discharge lamp, Xenon arc Lamp. 
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Visible region 
The tungsten lamp and tungsten halogen lamp are the most common source of visible 
radiation. 
1.2.2.4.2 Filters and Monochromators 
 The filters and Monochromators are used to disperse the radiation according to 
the wavelength.  
1.2.2.4.2.1 Filters  
 A light filter is a device that allows light of the required wavelength to pass 
but absorbs light of other wavelengths wholly or partially. Thus, a suitable filter can 
be selecting a desired wavelength band. It means that a particular filter may be used 
for a specific analysis. If analysis is carried out for several species, a large number of 
filters have to be used and interchanged. This method is very useful for routine 
analysis. 
Types of filters 
 Filters are two types, 
 i) Absorption filters 
ii) Interference filters 
 Absorption filters work by selective absorption of unwanted wavelengths and 
are made up of solid sheet of glass, coloured by a pigment or dispersed in glass and 
dyed gelatin. Interference filters work by selective transmission of selected 
wavelengths and they are made up of semitransparent metal film deposited on a glass 
plate and coated with dielectric material. 
1.2.2.4.2.2 Monochromators 
 Monochromators successfully isolates band of wavelengths usually much 
more than a narrower filter. The essential elements of a Monochromators are an 
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entrance slit, a dispersing element (prim or gratings) and an exit slit. The entrance slit 
sharply defines the incoming beam of heterochromatic radiation. The dispersing 
element disperses the heterochromatic radiation into its component wavelengths 
whereas exit slit allows the nominal wavelength together with a band of wavelength 
on either side of it. The position of the dispersing element is always adjusted by 
rotating it to vary the nominal wavelength passing through the exit slit. 
Types of Monochromators 
 1) Prisms 
 2) Gratings  
 A prism is made up of quartz (for UV region), glass (for visual range) and 
alkali halides (for IR). The main advantage of prisms is that they undergo dispersion 
giving wavelengths which do not overlap, but the main disadvantage is that they give  
non – linear dispersion.  A grating consists of large number of parallel lines ruled on a 
highly polished surface like alumina. Generally, gratings are difficult to prepare 
therefore, replica gratings are prepared from an original grating. This is done by 
coating the original grating with a film of an epoxy resin which after setting is 
removed to yield replica. Then replica is made reflective by aluminizing its surface. 
Gratings give linear dispersion but they suffer from an overlap of spectral orders. 
1.2.2.4.3 Sample cells 
These are containers for holding the sample and reference solutions and must 
be transparent to the radiation passing through generally with a thickness of 1 Cm. 
The choice of a sample cells are based on transmission characteristics at desired wave 
lengths, the path length, shape, size and the relative expense. The transmission 
characteristics are based on the construction materials. For UV region, the cells made 
up of quartz and for visible region, the cells are made of glass. 
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1.2.2.4.4 Detectors 
Detectors used in UV-Visible spectrophotometers can be called as photometric 
detectors. In these detectors the light energy is converted to electrical signal which 
can be recorded. The types of detectors used are Barrier Layer cell (or) Photo Voltaic 
cell, Photo tubes (or) Photo emissive tubes, Photomultiplier tubes and Photo diode. 
 1.2.2.4.5 Recorders 
 Detectors transmits the amount of light absorbed by a particular 
chemical species and only by that species is desired and by correcting the absorbance 
of solvent and other species in the solution. The recorders record the spectrum without 
any interferences compared with blank and they are user friendly. 
 
Schematic diagram of a single beam UV-Vis spectrophotometer 
 
 
Schematic diagram of a dual-beam uv-vis spectrophotometer 
 
(http://www.chemistry.adelaide.edu.au/external/soc-rel/content/uv-vis.html) 
Absorption spectroscopy is one of the most useful and widely used tools available 
to the analyst for quantitative analysis. The relation between the concentration of 
analyte and the amount of light absorbed is the basis of most analytical applications of 
molecular spectroscopy. This method of analysis is gaining importance due to simple, 
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rapid, precise, spectra of highly accurate and less time consuming. 
Spectrophotometric multi-component analysis can be applied where the drugs 
overlaps. In such cases of overlapping spectra, simultaneous equation can be framed 
to obtain the concentration of individual component otherwise multi-component 
analysis can be applied on any degree of spectral overlap provided that two or more 
spectra are not similar. The various spectroscopic techniques used for multi 
component analysis include 
1. Simultaneous equation method 
2. Absorption ratio method 
3. Geometric correction method 
4. Absorption correction method 
5. Orthogonal polynomial method 
6. Differential spectroscopy 
7. Derivative spectroscopy 
8. Area under curve method. 
1.2.2.5 Different spectroscopic methods  
 The assay of an absorbing substance may be quickly carried out by preparing a 
solution in a transparent solvent and measuring its absorbance at a suitable 
wavelength. The wavelength normally selected is a wavelength of maximum 
absorption (max), where small errors in setting the wavelength scale have little effects 
on the measured absorbance. 
1.2.2.5.1 Assay of substances in single component samples 
 Absorption spectroscopy is one of the most useful tools available to the 
chemist for quantitative analysis. The most important characteristics of photometer 
and spectrophotometric method are high selectivity and ease of convenience. 
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Quantitative analysis (assay of an absorbing substance) can be done using following 
methods. 
-    Use of      
   values 
-    Use of calibration graph (multiple standard method) 
-     By single or double point standardization method. 
1.2.2.5.1.1 Use of      
   values 
 This method can be used for estimation of drug from formulations or raw 
material, when reference standard not available. The use of standard value      
   
avoids the need to prepare a standard solution of the reference substance in order to 
determine its absorptivity, and is of advantage in situations where it is difficult or 
expensive to obtain a sample of the reference substance. 
1.2.2.5.1.2 Use of calibration graph 
 In this procedure the absorbance of a number of standard solutions of the 
reference substance at concentrations encompassing the sample concentrations are 
measured and a calibration graph is constructed. The concentration of the analyte in 
the sample solution is read from the graph as the concentration corresponding to the 
absorbance of the solution. Calibration data are essential if the absorbance has a non-
linear relationship with concentration, or if the absorbance or linearity is dependent on 
the assay conditions. In certain visible spectrophotometric assays of colourless 
substances, based upon conversion to coloured derivatives by heating the substance 
with one or more reagents, slight variation of assay conditions, e.g. P
H
, temperature 
and time of heating, may rise to a significant variation of absorbance, and 
experimentally derived calibration data are required for each set of samples. 
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1.2.2.5.1.3 Single or double point standardization 
          The single point procedure involves the measurement of the absorbance of a 
sample solution and of a standard solution of the reference substance. The standard 
and the sample solution are prepared in similar manner; ideally the concentration of 
the standard solution should be close to that of the sample solution. The concentration 
of the substance in the sample is calculated using following formula. 
Ctest = A test × Cstd / Astd 
Where, 
CtestandCstdare the concentration in the sample and standard solutions 
respectively. 
Atest and Astdare the absorbance of the sample and standard solutions 
respectively. 
 In double point standardization, the concentration of one of the standard 
solution is greater than that of the sample while the other standard solution has a 
lower concentration than the sample. The concentration of the substance in the sample 
solution is given by  
      
                                             
           
 
Where, 
Cstdis the concentration of the standard solution. 
Atest and Astdare the absorbance of the sample and standard solution 
respectively. 
Std1 and Std2 are the more concentrated standard and less concentrated 
standard respectively. 
 
 
  
23 
 
1.2.2.5.2 Assay of substances in Multicomponent Samples 
 The spectrophotometric assay of drugs rarely involves the measurement of 
absorbance of samples containing only one absorbing component. The pharmaceutical 
analyst frequently encounters the situation where the concentration of one or more 
substances is required in samples known to contain other absorbing substances which 
potentially interfere in the assay. If the recipe of the sample formulation is available to 
the analyst, the identity and concentration of the interferants are known and the extent 
of interference is the assay may be determined. Alternatively, interference which is 
difficult to quantify may arise in the analysis of formulations from manufacturing 
impurities, decomposition products and formulation excepients.  Unwanted absorption 
from this source is termed irrelevant absorption and, if not removed, imparts a 
systematic error to the assay of the drug in the sample. 
 The basic of all the spectrophotometric techniques for multicomponent 
samples is the property that at all wavelengths: 
a. The absorbance of a solution is the sum of absorbance of the individual 
components, or 
b. The measured absorbance is the difference between the total absorbance of the 
solution in the sample cell and that of the solution in the reference (blank) cell. 
The various spectroscopic techniques used for multi-component analysis are the 
fallowing 
1. Simultaneous equation method 
2. Absorption ratio method 
       3. Geometric correction method 
4. Absorption correction method 
       5. Orthogonal polynomial method 
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6. Differential spectroscopy 
       7. Derivative spectroscopy 
8. Area under curve method. 
1.3 CHROMATOGRAPHY (Sharma B.K., 2000; Gurdeep R. Chatwal et al., 2007) 
Chromatography may be regarded as “an analytical technique employed for 
the purification and separation of organic and inorganic substances”. It is also found 
useful for the fractionation of complex mixture and separation of closely related 
compounds such as isomers and isolation of unstable substances. Chromatography 
technique is based on the difference in the rate at which the components of a mixture 
move through a porus medium (stationary phase) under the influence of some solvent 
or gas (mobile phase). 
   The chromatographic method of a separation in general involves the following 
steps: 
a. Adsorption or retention of a substance or substance on the stationary phase. 
b. Separation of the adsorbed substance by the mobile phase. 
c. Recovery of the separated substance by a continuous flow of the mobile 
phase. The method being called elution. 
d. Quantitative and qualitative analysis of the eluted substance. 
1.3.1 Types Of Chromatography 
(http://www.buzzle.com/article/types-of-chromatography.html) 
Chromatography techniques are roughly classified on the basis of purpose for 
which they are used and method developed. The different types of laboratory 
techniques used in the separation of mixtures are grouped under an umbrella term, 
chromatography. The process through which constituents of a mixture are separated 
and analyzed by physical means is referred to as chromatography. Apart from the 
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different criteria of classification of chromatography discussed below, the basic 
criterion is the purpose for which this process is carried out. On the basis of this 
criterion, the process of chromatography is classified into analytical and preparative. 
The former is carried out for the purpose of measuring the amount of an analyte 
present in a mixture. On the other hand, preparative chromatography is used for 
separating the components of a mixture for their further use. Depending on the 
techniques used in chromatography, the process is broadly classified as adsorption 
and partition chromatography.  
1.3.1.1 Adsorption chromatography 
In this form of chromatography, the chemical mixtures in question are passed 
over an adsorbent bed. Different compounds present in the mixture get adsorbed on 
the bed at different rates. This process is mostly carried out for analytical separation. 
Adsorption chromatography is further divided into 'affinity' and 'ion-exchange' 
chromatography. 
1.3.1.2 Ion-exchange chromatography 
The mechanism of ion-exchange which is used in this form of chromatography 
allows carrying out the segregation of analytes. This kind of segregation/separation 
can be performed in 2 different modes, i.e. planar and column. Separation of charged 
compounds like peptides, amino acids, proteins, etc. takes place through a charged 
stationary phase. 
1.3.1.3 Column chromatography 
The column chromatography technique uses a set-up in which the stationary 
phase is placed in a column. There are two ways through which the stationary phase is 
positioned in a column: either it entirely fills the column or lines the walls of the 
column. 
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1.3.1.4 Planar chromatography 
The stationary phase is placed on a plane surface. The set-up is unlike the one 
used in column chromatography where stationary phase is placed in a column. Here, a 
plane surface is used. The plane surface could be anything from paper to glass. 
1.3.1.5 Affinity chromatography 
The non-covalent interaction which takes place between the analyte in 
question and certain molecules is the basis of working of affinity chromatography. 
Purification of proteins bound to tags is conducted with this technique. 
1.3.1.6 Partition chromatography 
In this separation technique, components of the given mixture are separated 
through the use of partition of a solute between two solvents. In the process, one of 
the solvents is immobilized by means of a substance present in the filter paper or 
column. 
1.3.1.7 Gel Filtration chromatography 
This technique is also known as gel permeation or size exclusion 
chromatography. Molecules of the mixture in question are separated on the basis of 
their size. Technically speaking, the process of separation is carried out on the basis of 
hydrodynamic diameter (size) of molecules. Larger molecules of the mixture are 
unable to enter the pores of media; therefore, molecules are washed out quickly. On 
the other hand, smaller molecules take more time to elute because they are able to 
enter the pores of media. 
1.3.1.8 High performance liquid chromatography 
In this type of chromatography, separation of compounds is carried out on the 
basis of their idiosyncratic polarities. Interaction of these compounds with the 
stationary phase of the column too is considered. Equipment needed for carrying out 
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high performance liquid chromatography includes a pump (used for moving the 
mobile phase and analyte through the column), stationary phase and a detector. 
Retention time for the analyte is also provided by the detector. Depending on the 
strength of interactions taking place between the analyte and stationary phase, 
retention time can vary. 
1.3.1.9 Gas chromatography 
This form of chromatography uses cylinders wherein gas is stored under 
pressure. These gases do the work of carrying the solute. The carrier gas that is 
commonly used in this chromatography is helium. Flame ionization detectors and 
thermal conductivity are used in gas chromatography. There are three sub-types of gas 
chromatography which include the following: gas-liquid chromatography, gas 
adsorption chromatography and capillary gas chromatography. In gas-liquid 
chromatography, an inert porous solid is used as the stationary phase. The stationary 
phase used in gas chromatography is a bed formed by an adsorbent. In capillary gas 
chromatography, the adsorbents form a layer on fused silica or glass which line the 
capillary walls. 
 
 
1.3.1.10 Pyrolysis gas chromatography 
This method of chromatography makes use of pyrolysis i.e. decomposition of 
the sample with the help of thermal power. The process of pyrolysis is followed by 
the regular procedure of gas chromatography. Resistive heating, inductive heating and 
heating in isothermal furnace are the three methods used for carrying out pyrolysis in 
this technique. The volatile fragments formed by heating (at a temperature of 600-
1000 °C) are separated by means of gas chromatography. 
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1.3.1.11 Reverse-phase chromatography 
This technique employs a method which is just opposite to that of normal 
phase chromatography. In reverse-phase chromatography, the stationary phase is 
made up of hydrophobic compounds; they attract the hydrophobic compounds present 
in the mobile phase. Here, the polarity of mobile phase is reduced in order to allow 
the hydrophobic molecule to elute. The technique of chromatography which is meant 
for separation of compounds from mixtures thus, holds immense importance in fields 
like biochemistry, biotechnology and many others. An attempt to list as many types of 
chromatography as possible is made in this write-up. 
1.3.2 High Performance Liquid Chromatography (Sharma B.K., 2006) 
The high performance liquid chromatography is thus a method of separation in 
which the stationary phase is contained in a column, one end which is attached to a 
source of pressurized liquid eluent (mobile phase). 
The choice of mobile phase is very important in HPLC and the eluting power 
of the mobile phase is determined by it’s over all polarity of the stationary phase and 
the nature of sample components. For normal phase separations the eluting power 
increases with increasing polarity of the solvent, but for reversed phase separations, 
eluting power decreases with increasing solvent polarity. 
1.3.2.1 HPLC separation modes 
          (http://www.justchromatography.com/chromatography/hplc-separation-modes) 
 
Chromatographic 
Mode 
Abrv. 
Column 
Type 
Mobile Phase Application 
Reverse-phase 
chromatography 
RPC Non-polar 
(e.g. C18) 
Polar mixture of 
water and organic 
solvent (e.g. 
Water-soluble 
samples 
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Chromatographic 
Mode 
Abrv. 
Column 
Type 
Mobile Phase Application 
acetonitrile) 
Normal-phase 
chromatography 
NPC Polar ( e.g. 
unbonded 
silica) 
Less-polar (than 
stationary phase) 
mixture of organic 
solvents (e.g. hexane, 
ethyl ether, 
chloroform, 
methylene chloride) 
Water-insoluble 
samples, isomer 
separation, and 
preparative 
HPLC 
Non-aqueous 
reverse-phase 
chromatography 
NARP Non-polar 
(e.g. C18) 
Mixture of organic 
solvents (e.g. ACN + 
methylene chloride) 
Very 
hydrophobic 
samples 
Hydrophilic 
interaction 
chromatography 
HILIC Polar (e.g. 
silica or 
amide-
bonded) 
Mixture of water 
organic solvents (e.g. 
ACN + H2O 
Highly polar 
samples that are 
poorly retained 
by reverse-phase 
mode 
Ion-exchange 
chromatography 
IEC Usually an 
organic resin 
that has 
charged 
groups able 
to bind ions 
of opposite 
charge 
Aqueous solution of a 
salt with buffer. 
Separating 
ionizable 
samples, large 
biomolecules 
(e.g. proteins, 
carbohydrates) 
Ion-pair 
chromatography 
IPC Non-polar 
(e.g. C18) 
Polar mixture of 
water and organic 
solvent (e.g. ACN) w/ 
an ion-pairing reagent 
(e.g. alkylsulfonates, 
trifluoroacetic acid) 
that interacts w/ 
sample ions of 
opositecharge 
Acids and bases 
that are weekly 
retained by 
reverse-phase 
Size-exclusion 
chromatography 
SEC Inert Aqueous or organic Large 
biomolecules, 
polymers. 
Separates by 
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Chromatographic 
Mode 
Abrv. 
Column 
Type 
Mobile Phase Application 
molecular 
weight. 
 
1.3.2.2 Elution techniques (Sharma B.K., 2006) 
Two types of elution techniques generally used. They are, 
i)  Isocratic elution 
One particle solvent or mixture is pumped through the whole analysis. 
ii) Gradient elution 
            For some determinations the solvent composition may be altered 
gradually gradient elution system can be classified as low pressure and high pressure 
system. In low pressure gradient elution system the eluent components are miner 
proportion varying with time at low pressure and the mixture is pumped in order to be 
delivered at high pressure to the column. In high pressure gradient elution system 
components or mixtures of fixed composition are each pumped by separate pump and 
then mixed at high pressure in a ratio varying with time. 
1.3.2.3 HPLC stationary phases (Robert D. Braun, 1986) 
HPLC can be performed by using the stationary phases. Generally the 
stationary phases are packed into a stainless steel column of 10-, 15-, 25-, 50-, 100-cm 
length with a diameter which is usually between 2 and 6 mm for analytical columns. 
Alumina is solid adsorbent which is widely used as a column packing material 
because alumina is basic it retains acidic compounds. Silica gel is also used as a 
packing material in the form of pure particles and as a pellicle on a solid support. A 
  
31 
 
pellicle is a thin layer or coating on a surface generally the pellicles used for HPLC 
have thickness about 1µm on glass beds which have diameter about 40mm. 
Mobile phases 
In HPLC, for solid adsorbent and liquid stationary phases (both normal and 
reverse phase) mixed solvents are used as the mobile phase .Generally the mobile 
phase consists of a mixture of polar solvents such as alcohol and non-polar solvents 
such as hydro carbons. 
The mobile phase must be chosen so as not to interfere with the measurement 
by the detector. For example, if an UV absorption detector is used the solvent cannot 
absorb UV radiation. Mixtures of methanol, ethanol or propanol with heptane and of 
chloroform with heptane are popular choices of HPLC mobile phase. 
1.3.2.4 Instrumentation(Willard et al., 1986) 
The general instrumentation for HPLC incorporates the following 
components:  
i. Mobile phase reservoir pump   ii. Injector 
iii. Column  iv. Detector and Data system 
 
Schematic diagram of HPLC(www.chromotech.com/ab/in/tech) 
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1.3.2.4.1 Mobile phase reservoir pump                                                   
The mobile phase must be delivered to the column over a wide range of flow 
rates and pressures to permit the use a wide variety of organic and inorganic solvents. 
The pump it seals and all connections must be made of materials chemically resistant 
to the mobile phase. A degasser is needed to remove the dissolved air and other gases 
from the solvent. Another desirable feature is the solvent delivery system is the 
capability for generating a solvent gradient. 
In HPLC pump should be able to operate to at least 100atm (1500 psi). A 
pressure suited to less expensive chromatographs however, 400atm (6000psi) is a 
more desirable pressure limit.  
Standard HPLC pump requirements are, 
a. Flow rate range 0.01 to 100 ml/ min.  
b. Pressure range: 1 to 5000 psi. 
c. Flow rate stability not more than 1% 
d. Pressure pulsations less than 1% 
The types of pumps used are, 
1.  Reciprocating Piston Pumps 
2.  Syringe-Type Pumps 
3.  Constant-Pressure Pumps 
The common problems in pumping liquids are,  
a. Solvent degassing  
b. Corrosion 
c. Compressibility  
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1.3.2.4.2 Injectors                                                  
In liquid chromatography, liquid samples may be injected directly and solid 
samples need only be dissolved in an appropriate solvent. The solvent need not be the 
mobile phase, but frequently it is judiciously chosen to avoid detector interference, 
column/component interference and loss in efficiency or all of these. It is always best 
to remove particles from the sample by filtering or centrifuging since continuous 
injections of particulate material will eventually cause blockage of injection devices 
or columns. Standard HPLC injector should be accurate in injecting volume in the 
range of 0.1 to 100 ml with high reproducibility and under high pressure (up to the 
4000 psi) and should produce minimum band broadening and should minimize 
possible flow disturbances. 
1.3.2.4.3 HPLC Columns 
HPLC columns are packed with very fine particles (usually a few microns in 
diameter). The very fine particles are required to attain the low dispersion that give 
the high plate counts expected of modern HPLC. Plate counts in excess of 25,000 
plates per column are possible with modern columns because of the dispersion 
associated with injection valves, detectors, data acquisition systems and the dispersion 
due to the higher molecular weight of real samples as opposed to the common test 
samples. LC columns, achieve their separation by exploiting the different 
intermolecular forces between the solute and the stationary phase and those between 
the solute and the mobile phase. The column will retain those substances that interact 
more strongly with the stationary phase than those that interact more strongly with the 
mobile phase. The main consideration with HPLC is the much wider variety of 
solvents and packing materials that can be utilized because of the much lower 
quantities of both which are required. In particular, very expensive optically pure 
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compounds can be used to make chiral HPLC stationary phases and may even be used 
as (disposable) HPLC solvents.   
Different types of columns are used. They are, 
1.  Analytical column 
2.  Short column 
3.  Narrow bore column 
4.  Guard column 
5.  Inline filters 
Analytical column variables are as follows: 
a. Length (10-30 cm) 
b. ID (4-10 mm) 
c. Packing (many kinds) 
d. Particles sizes (3-10 μm) 
e. Most common columns 250mmx4.6mm i.e. with 5μm particle size.
 
(http://www.waters.com/webassets/cms/category/media/other_images/primer_M- 
_Columnexamples.jpg) 
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1.3.2.4.4 Detectors 
Optical detectors are most frequently used. Current LC detectors have wide 
dynamic range normally allowing both analytical and preparative scale runs on the 
same instrument. 
Basic detector requirements 
An ideal LC detector should have the following properties: 
1. Low drift and noise level (particularly crucial in trace analysis). 
2. High sensitivity. 
3. Fast response. 
4. Wide linear dynamic range (this simplifies quantification). 
5. Low dead volume (minimal peak broadening). 
6. Cell design which eliminates remixing of the separated bands. 
7. Insensitivity to changes in type of solvent, flow rate, and temperature. 
8. Operational simplicity and reliability. 
9. It should be tunable so that detection can be optimized for different 
compounds. 
On-line detectors 
A. Refractive index. 
B. UV/Visible Fixed wavelength. 
C. UV/Visible Variable wavelength. 
D. UV/Visible Diode array. 
E. Fluorescence. 
F. Conductivity. 
G. Mass-spectrometric (LC/MS). 
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Off-line detector 
A. FTIR spiral disk monitor. 
Noise and drift 
The problem is to distinguish between the actual component and artifact 
caused by the pressure fluctuation, bubble, compositional fluctuation, etc. If the peaks 
are fairly large, one has no problem in distinguishing them. However, the smaller the 
peak, the more important is that the baseline be smooth, free of noise and drift. 
Baseline noise is the short time variation of the baseline from a straight line. Noise is 
normally measured "peak-to-peak": i.e., the distance from the top of one such small 
peak to the bottom of the next. Noise is the factor which limits detector sensitivity. In 
trace analysis, the operator must be able to distinguish between noise spikes and 
component peaks. The baseline should deviate as little as possible from a horizontal 
line. It is usually measured for a specified time, e.g., 1/2 hour or one hour and called 
drift. Drift usually associated to the detector heat-up in the first hour after power-on. 
Data systems 
The main goal in using electronic data systems is to increase analysis accuracy 
and precision while reducing operator attention. In routine analysis, where no 
automation is needed, a pre-programmed computing integrator may be sufficient. For 
higher control levels, a more intelligent device is necessary, such as a data station or 
minicomputer. 
The advantages of intelligent processors in chromatographs are, 
 Additional automation options become easier to implement. 
 Complex data analysis becomes more feasible. 
 Software safeguards can be designed to reduce accidental misuse of the 
system. 
  
37 
 
1.3.2.6 Summary of HPLC operation (Dong., 2006) 
1. Filter and degas mobile phase. 
2. Prime pump, rinse column with strong solvents and equilibrate column. 
3. Purge injection and make sure there are no air bubbles in the sample syringe. 
4. Perform system suitability test. 
5. Analyze sample. 
6. Process and report data. 
7. Rinse column and shut down pump and lamps. 
1.3.2.7 Checking for problems (Lloyd R.Snyderet al., 1997) 
As method development proceeds, various problems can arise, some of which 
are listed below. 
Problems Comments 
Low plate numbers Poor choice of column, poor peak shape effect. 
Column variability Poor choice of column, secondary retention effect. 
Short column life Poor choice of column, need for sample pretreatment. 
Retention drift Insufficient column equilibration, need for sample 
pre-treatment, loss of bonded phase. 
Poor quantitative 
precision 
Need for better calibration. 
 
1.3.2.8 HPLC method development (LloydR.Snyder et al., 1997) 
The wide variety of equipment, columns, eluent and operational parameters 
involved makes high performance liquid chromatography (HPLC) method 
development seem complex. The process is influenced by the nature of the analytes. 
The different stages in method development was given in the following flow chart 
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Selection of the HPLC method and initial system 
 
Selection of initial conditions 
 
Selectivity optimization 
 
System optimization 
 
Method validation 
 Quantitative analysis 
          The four primary techniques for quantitation are 
a. Normalized peak area 
b. External standard calibration method 
c. Internal standard calibration method  
d. method of standard addition 
a.Normalized peak area  
After completion of a run and the integration of all significant peaks in the 
chromatogram, the total peak area can then be calculated. The area percent of any 
individual peak is referred to as the normalized peak area. The technique of 
normalized peak area is actually not a calibration method per se, since there is no 
comparison to a known amount for any peak in the chromatogram. However, this 
technique is widely used to estimate the relative amounts of small impurities or 
degradation compounds in a purified material. 
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b. External standard calibration method 
The most general method for determining the concentration of an unknown 
sample is to construct a calibration plot using external standards. Standards solutions 
are prepared at known concentrations. A fixed volume of each standard solution is 
injected and analyzed, and the peak responses are plotted Vs concentration. The 
standard solutions are referred to as external standards, since they are prepared and 
analyzed in separate chromatograms from those of the unknown samples. Unknown 
samples are then prepared, injected and analyzed exactly in the same manner. 
c. Internal standard calibration method 
 Another technique for calibration involves the addition of an internal standard 
to the calibration solutions and samples. The internal standard is a different compound 
form the analyte, but one that is well resolved in the separation. The internal standard 
can compensate for changes in sample size or concentration to instrumental 
variations. With the internal standard method, a calibration plot is produced by 
preparing and analyzing calibration solutions containing different concentration of the 
compound of interest with a fixed concentration of the internal added. 
The Internal standard comply the following requirements: 
i. Well resolved from the compound of interest and other peaks. 
ii. Similar retention (k) to the analyte. 
iii. Should not be in the original sample. 
iv. Should mimic the analyte in any sample preparation steps. 
v. Does not have to be chemically similar to analyte. 
vi. Commercially available in high purity. 
vii. Stable and unreactive with sample or mobile phase. 
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viii. Should have similar detector response to the analyte for the concentration 
used. 
d. Method of standard addition 
 A calibration standard ideally should be prepared in a blank matrix of drug 
formulation components without the drug substance or an animal without added 
compound usually can be used for standard calibration solutions. The method of 
standard addition is most often used in trace analysis. In this approach, different 
weights of analyte(s) are added to the sample matrix, which initially contains an 
unknown concentration of the analyte. Extrapolation of a plot of response found for 
the standard addition calibration concentration to zero concentration defines the 
original concentration in the un spiked sample. 
1.3.2.9 System Suitability Parameters  
(Lloyd R.Snyder, 1997; Beckette and Stenlake, 2007) 
System suitability testing is an integral part of many analytical procedures. 
The tests are based on the concept that the equipment, electronics, analytical 
operations, and samples to be analyzed constitute an integral system that can be 
evaluated as such. System suitability test parameters to be established for a particular 
procedure depend on the type of procedure being validated.  
The parameters that are affected by the changes in chromatographic conditions are, 
 Column capacity factor (K1) 
 Resolution (Rs) 
 Selectivity () 
 Column efficiency (N) and 
 Peak asymmetry factor (As) 
 Tailing factor (T) 
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 Column capacity factor (K
1
) 
The retention of a drug with a given packing material and eluent can be 
expressed as retention time or retention volume, but both of these are dependent on 
flow rate, column length and column diameter. The retention is best described as a 
column capacity ratio (K), which is independent of these factors. The column capacity 
ratio of a compound (A) is defined as  
0
0A
0
0A
A
t
tt
V
VV
K



  
Where, 
VA = Elution volume of A 
V0 = Elution volume of a non-retained compound (void volume) 
At constant flow rate, retention times (tA and to) can be used instead of 
retention volumes. Retention data is sometimes expressed, relative to a known 
internal standard (B). The ratio of retention times (tA/tB) can be used, but the ratio of 
adjusted retention times  







oB
oA
tt
tt
 is better when data need to be transferred 
between different chromatographs. 
The values of ‘k’ of individual bands are increase or decrease with changes in 
solvent strength. In reversed phase HPLC, solvent strength increases with the increase 
in the volume of organic phase in the water / organic mobile phase. Typically an 
increase in percentage of the organic phase by 10 % by volume will decrease k’ of the 
bands by a factor of 2-3.  
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 Resolution (Rs) 
The resolution, Rs of two neighbouring peaks is defined by the ratio of the 
distance between the two peak maxima. It is the difference between the retention 
times of two solutes divided by their average peak width. For baseline separation, the 
ideal value of Rs is 2.0. It is calculated by using the formula, 
)WW(5.0
RtRt
R
21
12
f


  
Where,  
Rt1 and Rt2 are the retention times of components 1 and 2  
W1 and W2 are peak widths of components 1 and 2. 
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 Selectivity () 
The selectivity (or separation factor), , is a measure of relative retention of 
two components in a mixture. The ideal value of selectivity is 2. It can be calculated 
by using the formula,   
01
02
VV
VV


  
Where, V0 is the void volume of the column and V2 and V1 are the retention    
volumes of the second and the first peak, respectively. 
 
 Column efficiency 
Efficiency, N, of a column is measured by the number of theoretical plates per 
meter. It is a measure of band spreading of a peak. Smaller the band spread, higher is 
the number of theoretical plates, indicating good column and system performance. 
Columns with N ranging from 5,000 to 100,000 plates/meter are ideal for a good 
system. Efficiency is calculated by using the formula, 
2
2
16
W
Rt
N   
Where, 
Rt is the retention time and W is the peak width. 
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Peak asymmetry factor (As) 
Peak asymmetry factor, Ascanbe used as a criterion of column performance. 
The peak half width b of a peak at 10 % of the peak height, divided by the 
corresponding front half width a gives the asymmetry factor. 
a
b
AS   
Tailing factor (T) 
The tailing factor T, a measure of peak symmetry, is unity for perfectly 
symmetrical peaks and its value increases as tailing becomes more pronounced. 
In some cases, values less than unity may be observed. As peak asymmetry 
increases,integration, and hence precision becomes less reliable. 
  
      
  
 
Where, 
            W0.05 = width of peak at 5% height 
f = Distance from the peak maximum to the leading edge of the peak, the 
distance being measured at a point 5% of the peak height from the baseline. 
Limit  ≤ 2 is preferable.  
Height Equivalent to a Theoretical Plate (HETP) 
A theoretical plate can be of any height, which decides the efficiency of 
separation. If HETP is less the column is more efficient. If HETP is more, the column 
is less efficient. The height equivalent to a theoretical plate (HETP) is given by 
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1. VALIDATION (Michael E. Swartz et al., 2009) 
The validation is divided into different types. They are, 
Prospective Validation 
This method is employed when historical data of the product is not available 
or is not sufficient and in process and finished product testing is not adequate to 
ensure reproducibility or high degree of compliance to product likely attributes. 
Retrospective Validation 
 This provides trend of comparative result (i.e.) review and evaluation of 
existing information for comparison when historical data is sufficient and readily 
available. 
Concurrent Validation 
Based on information generated during implementation of a system for this 
extensive testing and monitoring are performed as part of initial run of the method. 
Re-Validation 
 Revalidation provides the evidence that changes in a process and are the 
process environment, introduced either intentionally or unintentionally, do not 
adversely affect process characteristic and product quality.  
There are two basic categories of revalidation. Revalidation in case of known 
change (including transfer of process from one company to another or from one site to 
another). Periodic revalidation carried out at scheduled intervals. 
 Reasons/Purpose of Validation 
 Setting standards of evaluation procedures. 
 Taking appropriate action in case of non-compliance. 
 Retrospective validation is useful for trend comparison of results compliance 
to cGMP/cGLP.                                                                                                                                       
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 Closer interaction with pharmacopoeia forum to address analytical problems. 
Enables scientist to communicate scientifically and effectively on technical 
matters. 
1.4.1 Analytical Parameters Used In Assay Validation As Per ICH Guidelines 
(Code Q2A; Q2B, ICH Guidelines 1994 and 1996) 
The objective of validation of an analytical procedure is to demonstrate that it 
is suitable for its intended purpose. A tabular summation of the characteristics 
applicable to identification, control of impurities and assay procedures is included. 
Types of Analytical Procedures to be validated 
The discussion of the validation of analytical procedures is directed to the four 
most common types of analytical procedures 
Identification Tests 
 Quantitative tests for impurities content. 
 Limit tests for the control of impurities. 
 Quantitative tests of the active moiety in samples of drug substance or drug 
product or other selected component(s) in the drug product. 
A brief description of the types of tests considered in this document is provided 
below. 
Identification tests are intended to ensure the identity of an analyte in a sample 
this is normally achieved by comparison of a property of the sample (example 
spectrum, chromatographic behavior, chemical reactivity etc.) to that of a reference 
standard. 
Testing for impurities can be either a quantitative test or a limit test for the 
impurity in a sample.  Either test is intended to accurately reflect the purity 
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characteristics of the sample. Different validation characteristics are required for a 
quantitative test than for a limit test. 
 Assay procedures are intended to measure the analyte present in a given sample. 
In the context of this document, the assay represents a quantitative measurement of 
the major component(s) in the drug substance. For the drug product, similar 
validation characteristics also apply when assaying for the active or other selected 
component(s). The same validation characteristics may also apply to assays 
associated with other analytical procedures.  
The objective of the analytical procedure should be clearly understood since this 
will govern the validation characteristics which need to be evaluated. 
 
Figure: Workflow for Evaluation and Validation of Standard Methods 
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Typical Validation Parameters 
 Accuracy 
 Precision 
 Range 
 Specificity 
 Linearity 
 Detection Limit 
 Quantification Limit 
 Ruggedness 
 Robustness 
 Accuracy 
The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or on an 
accepted reference value and the value found. 
Precision 
 It expresses as degree of agreement among individual test results when 
procedure or method is applied to a homogeneous sample, usually expressed as SD or 
RSD. It is a measure of degree of repeatability or reproducibility under normal 
conditions. A more comprehensive definition proposed by the ICH divides precision 
into three types 
1. Repeatability. 
2. Intermediate Precision. 
3. Reproducibility. 
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Range 
 The range of a method can be defined as the upper and lower concentrations 
for which the analytical method has adequate accuracy, precision and linearity. The 
range of concentrations examined will depend on the type of method and its use. 
 Specificity 
 Ability of the method to measure accurately and specifically the analyte of 
interest in presence of matrix and other components likely to be present in the sample 
matrix and impurities, degradation products and other related substances. For this, 
one may compare the test results of analysis of samples containing other ingredients 
or impurities or degradation products or related substances or placebo ingredients 
with those obtained from analysis of sample without these, i.e., the method must 
allow distinct analytical measurement of analyte of interest and exclusion of all other 
relevant interferences. If the impurities or degradation products or potential 
contaminants are not available one can apply a proposed method to the strain and 
stress (heat, light, humidity) samples. Degree of agreement among results will explain 
specificity of the method. If the impurities or degradation products are not available, 
one may carryout additional purity tests by chromatography-HPLC or HPTLC. 
 Linearity 
 The linearity of an analytical procedure is its ability to obtain test results, 
which are directly proportional to the concentration of analyte in the sample. 
Linearity can be assessed by performing single measurements at several 
analyteconcentrations,A linearity correlation coefficient above 0.999 is acceptable for 
most methods, especially for major components in assay methods. The range of an 
analytical procedure is the interval between the upper and lower concentration of 
analyte in the sample. 
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 Detection limit 
The Detection Limit of an individual analytical procedure is the lowest 
amount of analyte in a sample which can be detected but not necessarily quantities as 
an exact value. The detection limit (LOD) may be expressed as 
    
    
 
 
Where, 
 = the standard deviation of the response. 
               S = the slope of the calibration curve (of the analyte). 
 Quantification limit 
LOQ is defining as the lowest concentration of the substance (analyte) in a 
sample that can be estimated quantitatively with acceptable precision, accuracy and 
reliability by a given method under stated experimental conditions. Quantification 
Limit (LOQ) may be expressed as  
    
   
 
 
Where, 
  = the standard deviation of the response. 
           S   = the slope of the calibration curve (of the analyte). 
Ruggedness 
It is the measure of the capacity of the analytical method to remain unaffected by 
small but deliberate variations in procedure. It provides an indication about variability of 
the method during normal laboratory conditions. 
  
 
 
  
51 
 
Robustness 
The concept of robustness of an analytical procedure has been defined by the ICH as 
“A measure of its capacity to remasin unaffected by small, but deliberate variations in 
method parameters”. The most important aspect of robustness is to develop methods that 
allow for expected variations in the separation parameters. 
General acceptance limits 
S.No. 
Characteristics Acceptance Criteria 
1 
Accuracy  
Assay limit- 98-102% 
 Recovery - 80,100,120%.with a deviation of + 2  
 
2 
Precision 
A)Repeatability 
b)Intermediate           
precision 
 
% RSD < 2 
% RSD < 2 
3 
Specificity/ selectivity No interference 
4 
Detection Limit S/N > 2 or 3 
5 
Quantitation  Limit S/N > 10 
6 
Linearity r > 0.999 
7 
Range 80-120% 
8 
Stability >24hr or > 12hr 
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1.5 BASIC STATISTICAL PARAMETERS 
(Gupta, et al., 1995; Bolton, et al., 2004; Mendham, et al., 1994) 
 Statistical techniques have been widely used in many diverse areas of 
scientific investigation. Statistical applications have been recognized as crucial to 
quality control procedure, test, specification and definitions. Principle of modern 
analytical techniques and skill in their application are necessary attribute of the 
successful pharmaceutical analyst, thus does not ensure the satisfactory solution of all 
the problem that may encountered. Some auxiliary knowledge methods those can aid 
the analyst in designing experiment, collecting data, and interpreting the result. 
1.5.1 Linear Regression 
 Linear regression is a statistical technique that defines the functional 
relationship between two variables by best-fitting straight line.  Once a linear 
relationship has been shown to have a high probability by the value of the correlation 
coefficient ‘r’, then the best straight line through the data points has to be estimated. 
This can often be done be done by visual inspection of the calibration graph, but in 
many cases it is far more sensible to evaluate the best straight line by linear regression 
(the method of least squares). 
The equation of straight line is  
y = mx + c 
Where, y the dependent variable is plotted as result of changing x, the independent 
variable. 
         To obtain the regression line ‘y on x’ the slope ‘m’ of the line and the intercept 
‘c’ on the y axis are given by the following equation. 
  
                
           
and   
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1.5.2 Correlation Coefficient (r) 
It is a procedure commonly used to characterize quantitatively the relationship 
between variable. Correlation is related to linear regression.  To establish whether 
there is a linear relationship between two variables x1 and y1, use Pearson’s 
correlation coefficient r. 
  
             
                              
 
  
 
Where n is the number of data points. 
 The value of r must lie between +1 and -1, the nearer it is to +1, the greater the 
probability that a definite linear relationship exists between the variables x and y, 
values close to +1 indicate positive correlation and values close to -1 indicate negative 
correlation values of ‘r’ that tend towards zero indicate that x and y are not linearly 
related (they made be related in a non-linear fashion). 
1.6.3 Standard Deviation (SD) 
          It is commonly used in statistics as a measure of precision statistics as a 
measure of precision and is more meaningful than is the average deviation. It may be 
thought of as a root-mean-square deviation of values from their average and is 
expressed mathematically as 
 
1N
xx
S
ni
1i
i





  
Where, 
S is standard deviation. 
ZIf N is large (50 or more) then of course it is immaterial whether the term in 
the denomination is N -1 or N  
Σ       = sum 
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x       = Mean or arithmetic average. 
x -x  = deviation of a value from the mean. 
N      = Number of observations. 
1.5.4 Percentage Relative Standard Deviation (%RSD) 
 It is also known as coefficient of variation (CV). It is defined as the standard 
deviation (SD) expressed as the percentage of mean. 
C 100
x
S.D
RSD  %or  V 
 
          Where,  
SD = the standard deviation, 
x  = Mean or arithmetic average. 
 The variance is defined as S
2
 and is more important in statistics than S itself.  
However, the latter is much more commonly used with chemical data. 
 
1.5.5 Standard Error of Mean (SE) 
 Standard error of mean can be defined as the value obtained by division of 
standard deviation by square root of number of observations. It is mathematically 
expressed as  
n
S.D.
S.E.   
   Where, 
 SD = Standard deviation. 
        n = number of observation 
1.6.6 Confidence Interval (CI) 
 A confidence interval gives an estimated range of values which is likely to 
include a unknown population parameter, the estimated range being calculated from a 
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given set of sample data. A confidence interval with a particular confidence level 
(95% selected by the user) is intended to give the assurance that, if the statistical 
model is correct then the interval could deliver the true value. 
Confidence interval for a normal population, 
 
Where  
     = Sample mean 
   = upper  critical value of standard normal distribution 
    N = Size of sample  
    σ = Standard deviation 
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REVIEW 
  
56 
 
2. LITERATURE REVIEW 
2.1 DRUG PROFILE 
2.1.1 Alverine Citrate 
(Martindale The extra Pharmacopoeia, 2005;Martindale, The complete drug 
reference,2005;TheMerck  Index,2006; Clark's Isolation of Drugs and Poisons, 2004; 
                             -   -         5/6/14; 
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=21718) 
 
 Molecular structure 
 
Chemical name 
N-Ethyl-3,3-diphenyl diproyllamine citrate 
Molecular formula 
 C20H27NC6H8O7 
Molecular weight 
473.53 
Category 
 It is used as an Anti- spasmodic. It is used mainly for the treatment of gastro- 
intestinal and biliary tract disorders, including irritable bowel syndrome. 
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Description  
It is a white to off-white powder having a sweet odour and slightly bitter taste. 
Solubility  
 It slightly soluble in chloroform, sparingly soluble in ethanol and very slightly 
soluble in ether  
pka value 
3.3 to  4.5 
Storage  
  It should be stored in a well-closed container and protected from light.  
 Identification 
1. Melting point 
Standard value Observed average value* 
100 to 103 102.83 
                  *Average of six observations 
2. Infra-red spectrum was recorded and shown in figure – 1. 
Mechanism of action 
 Agents that inhibit the actions of the parasympathetic nervous system. The 
major group of drugs of drug used therapeutically for this purpose is the muscarinic 
antagonists. 
Pharmacokinetics 
    Alverine Citrate is observed from gastrointestinal tract following oral 
administration and is rapidly metabolized to active metabolite, peak plasma 
concentration of which occur 1 to 1.5 hours after an oral dose. Further metabolism 
into inactive metabolites occurs; metabolites are excreted in urine by active secretion. 
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Uses and administration 
 Alverine Citrate is an anti spasmodic that acts directly on intestinal and uterine 
smooth muscle. It is used for relief of smooth muscle spasm in treatment of gastro 
intestinal disorders such as irritable bowel syndrome. It also used in treatment of 
dysmenorrhoea. Alverine Citrate  is given by mouth as citrate in doses of 60 mg to 
120 mg one to three times daily. It has also been given by suppository as the base in 
dose of 80 mg two or three times daily. Alverine Citrate 67.3 mg is approximately 
equivalent to 40 mg of Alverine Citrate. 
Adverse Effects and Precautions 
 Nausea, headache, pruritus, rash and dizziness have been reported. Allergic 
reaction, including anaphylaxis, have also occurred. Alverine Citrate is contra-
indicated in patients with intestinal obstruction or paralytic ileus. 
2.2 REPORTED METHODS 
2.2.1. Analytical Methods 
   2.2.1.1. Kumar M. et al (2013) reported” Forced degradation study of 
Alverine Citrate in acid by UV spectrophotometry method.”Alverine Citrate has 
been studied  under acid hydrolytic stress condition. The study can give the results, 
whether the Alverine Citrate shows the stability or shows the degradation under the 
acidic condition. The degradation behaviour of Alverine Citrate was carried out as per 
the standard procedures and guidelines. The primary aim is to evaluate the stability of 
drug substance and formulation. Various stress condition have been used to detect the 
stability of Alverine Citrate. Forced acid hydrolytic degradation of Alverine Citrate 
was performed in bulk and solid oral formulation using O.1 M Hydrochloric acid at 
room  temperature in different time interval such as 30 minutes, 60 minutes and       
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90 minutes. The resulting solutions were analyzed for content by UV 
spectrophotometry at maximum absorption of 257nm.  
 2.2.1.2.  Oval N. et al ( 2013) ) reported “IR quantification of Alverine 
Citrate in bulk and oral dosage form” Alverine Citrate is chemically N-Ethyl -3-
phenyl –N-( 3- phenyl propyl) propan -1-amine, commonly used as a smooth  muscle 
relaxant, antispasmodic in irritable  bowel syndrome and dysmenorrheal agent. A 
simple and sensitive infrared spectrophotometric method has been developed for  the 
estimation of Alverine Citrate in capsule dosage form. The method involves the 
determination of Alverine Citrate by absorbance and peak area method of IR 
spectroscopy . The sample was analysed by KBr pellet method; IR band at 2052 Cm-1 
was considered for quantification. The calibration graph were plotted with                 
a) absorbance against concentration   b) area calculated by in built software against 
concentration. 
 2.2.1.3. Niraimathi V. et al (2013) reported “Quantification of Alverine 
citrate in pharmaceutical formulation by UV spectrophotometry”. Alverine is 
chemically N-Ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine,commonly used as 
a smooth muscle relaxant, antispasmodic in irritable bowel syndrome and 
dysmenorrhoea. Three new, simple, sensitive and reproducible spectrophotometric 
methods  have been developed for the estimation of Alverine Citrate in oral dosage 
form. Method A and Method B involves the determination of Alverine Citrate by first 
derivative and second derivative spectrophotometry. The fundamental spectrum 
obtained was derivatized to first order and the amplitude of the negative peak was 
measured at 210 nm. A calibration graph was obtained by plotting concentration 
versus amplitude. Method C involved the determination of Alverine Citrate by area 
under the curve. The area under the curve between 200-225 nm  was measured by 
  
60 
 
using inbuilt software. The inbuilt software calculates the area bound by the curve and 
the horizontal axis. The horizontal axis is selected by entering the wavelength range 
over which the area has to be calculated. A linearity graph was constructed by plotting 
concentration versus area. The sample concentration for all the methods were 
obtained by interpolation. The results of the analysis was validated statistically and by 
recovery studies. It was also found that the excipients of the formulation did not 
interfere in the analysis. 
 2.2.1.4. Rhul C. Gavhane et al (2011) reported “Liquid chromatography/ 
Tandem mass spectrometry simultaneous determination of Alverine and its 
metabolite, monohydroxy Alveine,in human plasma:application to a 
pharmokinetic study”. A rapid and sensitive LC-MS-MS method for the 
determination of Alverine and its major metabolite, monohydroxy Alverine in human 
plasma using imipramine as an internal standard was developed and validated. The 
analytes were extracted from 0.5 ml aliquots of human plasma by solid phase 
extraction, using oasis cartridge. Chromatographic separation was carried on Thermo 
Gold C18 column (50 × 4.6 mm, 5 μ) at 30 °C, with isocratic mobile phase, a flow rate 
of 0.4 ml/ min and a total run time of 3.5 min. Detection and quantification were 
performed using a mass spectrometer in the selected reaction-monitoring mode with 
positive electro spray ionization. 
 2.2.1.5. Yedhupati Kondappa Naidu et al (2010) reporte "Simultaneous 
Quantification of Alverine and Its Metabolite P-Hydroxy Alverine In Human 
Plasma with Robotic Liquid-Liquid Extraction by using Fully Validated LC-
MS/MS and its Application to A Bioequivalence Study". A sensitive and selective 
method is described for the quantification of Alverine and P-hydroxy Alverine 
inhuman plasma using ticlopidine as internal standard. The bioanalytical approach 
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consists of Robotic Liquid -Liquid extraction with diethyl ether: dichloromethane                 
(70:30 chromatographic separation of 10 µl of injected sample with Thermo BDS 
Hypersil (C18, 4.6 X 50 mm) column using acetonitrile: 10 mM ammonium formate 
buffer (90:10 v/v) as mobile phase followed by quantification with mass detector in 
selective reaction monitoring mode using electro spray ionization mode (ESI) as an 
interface. 
 2.2.1.6. Gosh C. et al (20l0) reported “A rapid and most sensitive liquid 
chromatography/Tandem mass spectrometry method for simultaneous 
determination of Alverine and its major metabolite, para hydroxy Alverine, in 
human plasma: application to a pharmacokinetic and bioequivalence study”. A 
rapid and highly sensitive method for the determination of Alverine) and its 
metabolite, Para hydroxy Alverine, in human plasma using LC-MS/MS in positive ion 
electro spray ionization in multiple reactions monitoring mode was developed and 
validated. The procedure involves a simple solid phase extraction Chromatographic 
separation was carried out on a Hypersil gold C18 column (50 mm x 4.6 mm,              
5 micron) with an isocratic mobile phase and a total run time of 1.5 min.  
  2.2.1.7. Novel A. Gomesh et al (2009) reported "Validated LC-MS/MS 
method for Determination of Alverine and one of its hydroxy metabolites in 
human plasma along with its application to a bioequivalence study”. The present 
research work involves a first of its kind rapid and sensitive liquid chromatography-
tandem mass spectrometry (LC-MS/MS) method developed and validated for 
simultaneous analysis of Alverine and one of its hydroxy metabolites, Para Hydroxyl 
Alverine  in human plasma. The analytes were extracted from the matrix using a 
simple solid-phase extraction procedure. Mebeverine was used as the internal 
standard for  both analytes. Akromasil C8 column provided chromatographic 
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separation of analytes followed by detection with mass spectrometry. The method 
involves simple isocratic chromatography conditions and mass spectrometric 
detection in the positive ionization mode using an  API 5000 MS/MS system.  
2.2.2. Clinical Methods 
 2.2.2.1. Poluektova Ye A.  et al(2012) reported “Combined Alverine Citrate 
and simeticone in preparation in the treatment of irritable bowel syndrome”.  To 
assess the effect of combined drug meteospasmyl on intensity of clinical symptoms of 
irritable bowel syndrome. Retrospective analysis of efficacy and safety of 
meteospasmyl in 30 patients with IBS diagnosis, confirmed by conformity of 
complaints to Rome-III criteria and absence of pathological changes at laboratory and 
instrumental investigations was carried out. 
 2.2.2.2.  Beyazit et al (2011) reported “Inclusion of a spasmolytic in bowel 
cleansing : a prospective randomised study”  The quality of colon cleansing and 
the tolerance of patients to the procedure are two major determinants of the quality of 
a colonoscopy. Many bowel cleansing regimens are known, but there is no ideal 
regimen. Alverine Citrate (Relaxyl, spasmonal) is a spasmolytic agent that has been 
shown to affect responses of mechanoreceptors of the intestine to both mechanical 
and chemical stimuli. Patients who underwent colonoscopies at four centres were  
randomly assigned two different bowel cleansing  procedures . The bowel cleansing 
methods were oral sodium phosphate (NaP) (GroupI) and oral NaP plus Alverine 
Citrate (Group II). Patients were randomized into one of the regimens. The quality of 
colon cleansing  was assessed by an endoscopist with an  empirical, clinically 
meaningful 3 point scale. 
 2.2.2.3. Wittmann T. et al (2010) reported “ The Efficacy of Alverine 
Citrate/Simeticone Combination on Abdominal Pain/discomfort in Irritable 
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bowel Syndrome - a randomized, double-blind, Placebo-controlled Study” 
 Alverine citrate and simeticone combination has been used for almost 20 years in 
irritable bowel syndrome (IBS), but supportive scientific evidence of efficacy was 
limited. To evaluate the efficacy of Alverine Citrate and simeticone combination in 
patients with IBS-related abdominal pain/discomfort. A total of 412 IBS patients 
meeting ROME III criteria were included in this double-blind randomized placebo-
controlled study if their abdominal pain/discomfort intensity was at least 60 mm on a 
0–100 mm visual analogue scale (VAS) during a 2-week run-in treatment-free period.  
 2.2.2.4. Donghong ju et al (2009) reported “Dycolonie and Alverine Citrate 
enhance the cytotoxic effects of proteasome inhibitor MG 132 on breast cancer 
cells”.  Proteasome  is an important target in cancer therapy. To enhance the efficacy 
of  proteaseome inhibitors is a challenging task due to paucity of understanding the 
functional in mammalian cells. Taking advantage of the knowledge gained from 
saccharomyces cerevisiae, we show that dyclonine and alverine citrate, the major 
components of two over – the- counter medicines, can substantially enhance the 
cytotoxic effects of protesome inhibitor MG132 on breast cancer cells. This study also 
highlights an important yeast genetic approach to identification of potential 
therapeutics that can be used for combination therapy with proteasome inhibitors. 
 2.2.2.5.  Engin Altintas et al ( 2008)  reported “Alverine citrate plus 
simethicone reduces cecal intubation time in colonoscopy - A randomized study" 
Successful colonoscopy depends on the insertion of the instrument to the cecum, a 
detailed examination, and minimal discomfort to the patient during the procedure. The 
aim of this study was to determine the effects of alverine citrateplus simethicone on 
the cecal intubation time, colonicspasm and bowel cleanliness. A prospective, 
randomized, controlled trial in a consecutive series of patients was conducted to 
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compare alverine citrate as an antispasmodicagent for relaxation of spasm with 
elective colonoscopy. The drug used consisted of 60 mg alverine citrate plus 300 mg 
simethicone. Sodium phosphate soda and enema were recommended for bowel 
cleansing. During colonoscopy, spasticity, difficulty of the procedure, pain, and 
cleanliness of the colon were scored between 0-4. The time required to reach the 
cecum was recorded as minutes. 
 2.2.2.6.  Mehmet Arhanet al (2004)  reported “Alverine citrate induced acute 
hepatitis”  Alverine citrate is a commonly used smooth muscle relaxant agent. A 
MEDLINE search on January 2004 revealed only 1 report implicating the 
hepatotoxicity of this agent. A 34-year-old woman was investigated because of the 
finding of elevated liver function tests on biochemical screening. Other etiologies of 
hepatitis were appropriately ruled out and elevated enzymes were ascribed to alverine 
citrate treatment. Although alverine citrate hepatotoxicity was related to an immune 
mechanism in the first case, several features such as absence of predictable dose-
dependent toxicity of alverine citrate in a previous study and absence of 
hypersensitivity manifestations in our patient are suggestive of a metabolic type of 
idiosyncratic toxicity. 
 2.2.2.7.Mitchell S.A. et al (2002) reported “Alverine citrate fails to relieve 
the symptoms of irritable bowel syndrome: results of a double-blind, 
randomized, placebo-controlled trial”  Alverine citrate has been used in the 
treatment of irritable bowel syndrome for many years. To compare the efficacy and 
safety of a new formulation of alverine citrate, a 120-mg capsule, with placebo given 
three times daily for 12 weeks. One hundred and seven patients with irritable bowel 
syndrome were entered into this three-centre, double-blind, randomized, placebo-
controlled, parallel group trial. The primary end-point was relief of abdominal pain 
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indicated by improvement in the scores for severity and frequency. Secondary 
efficacy variables included scores for other clinical symptoms and for overall well-
being. The severity and frequency of abdominal pain improved in 66% and 68% of 
patients treated with Alverine citrate vs. 58% and 69% of the placebo group, but these 
differences were not significant. The mean percentage reduction in the scores for 
abdominal pain from baseline to the final assessment, although greater in the Alverine 
citrate group (43.7%) compared with the placebo group (33.3%), was not statistically 
significant. Conclusions: Alverine citrate is no better than placebo at relieving the 
symptoms of irritable bowel syndrome. Future trials should be designed to take into 
account the high and persistent placebo response seen in this condition. 
  
 
             
 
AIM 
AND PLAN OF 
WORK 
 
 
 
 
 
  
66 
 
3. AIM AND PLAN OF WORK 
3.1.  AIM OF WORK 
The drug analysis plays an important role in the development, manufacture 
and therapeutic use of drug. Most of the pharmaceutical industries do the quantitative 
chemical analysis  to ensure that the raw material used and the final product thus 
obtained meet certain specifications  and to determine how much of each components 
are present in the final product. 
Standard analytical procedure for newer drugs or formulation may not be 
available in pharmacopoeias hence it is essential to develop newer analytical methods 
which are precise, accurate, specific, linear, simple and rapid. UV and HPLC grades 
of solvents used for respective determination and solvent should readily available and 
cheaper. The solvent should be completely extracting the active ingredient from 
formulation. 
Alverine citrate is a  muscarinic antagonist. It is used for the treatment of 
smooth muscle relaxant and first approved in the USA. The drug is available in the 
brand name Spasmonal  in  US and U.K. 
Extensive literature survey revealed that the derivative UV 
Spectrophotometric method was reported for the estimation of Alverine Citrate in 
bulk and in formulation. LC-MS/MS method also reported for the detection of 
Alverine Citrate in plasma. 
  However there ias no evidence for the estimation of Alverine Citrate by UV 
spectrophotometry and  RP-HPLC in bulk and in  capsules formulation. So, an 
attempt was made to develop simple, cost effective and accurate UV 
spectrophotometric and  RP-HPLC methods for the estimation of  Alverine Citrate in 
bulk and in  capsule formulation and to validate the developed methods.  
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3.2.  PLAN OF WORK 
3.2.1.  Survey on Literature 
The survey on literature performed for  alverine citrate  for their 
physiochemical properties, solubility, pharmacology and analytical techniques. So 
this basic information gives notation for newer method development. 
3.2.2. Method Development 
1) Identification of drug by its melting point and IR spectral studies. 
2) Selection of suitable solvents for quantitative extraction of drug present in the 
formulations. The solvent should be readily available, economical and of analytical 
grade for UV-spectroscopic method and HPLC grade solvents for  RP-HPLC method. 
The solvent should not interact with the compound of interest and its structural 
characteristics. 
3) Selection of method for analysis, depending on the spectral characteristics of the drug. 
4) Development of simple cost effective and accurate RP-HPLC method. 
5) Analysis of marketed formulation by the proposed methods. 
6) Validation of the development methods as per ICH guidelines. The Parameters used to 
validate the developed method are Specificity, Linearity, Range, Accuracy, Precision, 
Limit of Detection, Limit of Quantification,  Robustness and Ruggedness 
7) Statistical analysis of  the developed analytical methods. 
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4. MATERIALS AND METHODS 
4.1.  MATERIALS USED 
4.1.1.  Drugs  
Alverine Citrate  raw material was   brought from Meda Pharmaceuticals, US. 
4.1.2 Formulation 
Spasmonal  capsules  formulation containing  Alverine citrate 120 mg was 
purchased from  US market. 
4.1.3.  Reagents and Chemicals 
All  the  chemicals and solvents used  were  of  analytical   grade  and  HPLC  
grade .The chemicals and solvents used for the study were Methanol (HPLC grade), 
Acetonirile (HPLC grade), ortho phosphoric acid and Water for HPLC, Hydrochloric 
acid (Analytical grade). 
4.1.4.  Instruments Used 
Different instruments used to carry out the present work are 
 Shimadzu AUX- 220 Digital balance. 
 Shimadzu- 1700 Double Beam UV-Visible Spectrophotometer with a pair of 10 mm 
matched quartz cells. 
 ELICO SL-210 Double Beam UV- Visible Spectrophotometer with pair of   
10 mm matched quartz cells. 
 Soltec - Sonica Ultrsonic Cleaner - Model 2200 MH. 
 Remi Centrifuge Apparatus 
 Cyberlab Micropipette. 
 HPLC 
  Shimadzu SPD – 20A UV – Visible detector.  
   Shimadzu LC – 20 AD solvent delivery module   
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4.1.5 . Specifications Of Instruments 
4.1.5.1. Shimadzu UV - 1700 Double Beam UV Visible Spectrophotometer         
             Elico - SL 210 Double Beam UV- Visible Spectrophotometer 
(Shimadzu Instruction Manual; Elico Instruction Manual) 
SPECIFICATIONS 
Light source 
Tungsten halogen lamp (W), Deuterium lamp (D2).  
Light source positions automatic adjustment 
mechanism 
Monochromators Concave holographic grating with 1200 lines/mm 
Detector Photodiode 
Stray light <0,05%T at 220 nm with NaI 10 g/lt 
Measurement Wavelength range 190 to 1100 nm 
Spectral Band Width 1.8 nm 
Wavelength Accuracy ±0.5 nm 
Spectral repeatability ±0.2 nm 
Spectral readability 0.1 nm 
Recording range ±3.0000 Abs 
Photometric accuracy ±0.005 Abs (at 1.0 Abs), ± 0.010 Abs (at 1.5 abs) 
Operating temperature/ Humidity 
Temperature range: 15 to 35º C 
Humidity range: 35 to 80% (15 to below 30º C) 
 35 to 70% (30 to below 35º C) 
4.1.5.2.  Shimadzu AUX- 220 digital balance  (Shimadzu instruction manual) 
SPECIFICATIONS 
Weighing capacity 200 gms 
Minimum display 0.1 mg 
Standard deviation ≤ 0.1 mg 
Operating temperature range 5 to 40° C 
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4.1.5.4. Shimadzu HPLC(Shimadzu Instruction Manual) 
Detector Specifications 
Light source Deuterium arc lamp 
Wavelength range 190 to 700 nm 
Spectral Band Width 5 nm 
Wavelength Accuracy  1 nm 
Cell path length 10 nm 
Cell volume 20 l 
Operating temperature range 4 to 40C (39 to 104F) 
Recording range 0.0001 to 4.000 AUFS 
Operating Temperature/ 
Humidity 
4 to35C/ 75 % 
Pump Specifications 
Pump type Double reciprocating plunger pump 
Pumping methods Constant flow delivery and constant pressure delivery 
Suction filter 45 m  
Line filter 5 m mesh 
Operating 
temperature 
4 to 40C 
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4.2.  METHODS 
 In the present work, an attempt was made to develop and validate simple, 
precise and accurate methods for the estimation of  Alverine Citrate in pure and in 
tablet dosage form by UV-Spectroscopy and  RP-HPLC. 
4.2.1.   UV Spectroscopic Method 
4.2.1.1. Selection of solvent 
 The solubility of  Alverine Citrate was determined in variety of solvents as per 
Indian Pharmacopoeia. Solubility was carried out in different polar and non-polar 
solvents. From the solubility data 0.1M Hydrochloric acid was selected as solvent for 
the analysis of Alverine Citrate. 
4.2.1.2.  Preparation of standard stock solution 
40 mg of Alverine citrate standard substance was weighed and transferred into 
100 ml volumetric flask, dissolved in 0.1M Hydrochloric acid and made up to the 
volume with 0.1M Hydrochloric acid. This solution contains 400 g/ ml 
concentration. 
4.2.1.3. Selection of wavelengths for estimation and stability studies 
 The standard stock solution was further diluted with 0.1M Hydrochloric acid 
to get the concentration of 12 g/ ml and the solution was scanned between                 
200 - 400 nm using 0.1M Hydrochloric acid as blank. From the spectra, λ max was 
found to be 207 nm and was selected as an analytical wavelength.  
The stability was performed by measuring the solution at different time 
intervals. It was observed that Alverine Citrate  in 0.1M Hydrochloric acid was stable 
up to 5 hours at the selected wavelength. 
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4.2.1.4.  Preparation of calibration graph 
 From the  standard stock solution  1 – 6 ml were transferred into a series of    
100 ml volumetric flasks and made up to the volume with 0.1M Hydrochloric acid. 
The absorbance of different concentration solutions were measured at 207 nm. The 
calibration curve was constructed by plotting concentration Vs absorbance.          
Alverine  Citrate  was linear with the concentration range of 4 - 24 g/ ml at 207 nm. 
4.2.1.5 . Quantification of raw material 
 3 ml of standard solution was taken into a series of six 100 ml volumetric 
flasks and the volume was made up to mark with 01.M Hydrochloric acid. The 
absorbance of these solutions was measured at 207 nm. The amount of Alverine 
Citrate  present in the raw material was determined by using slope and intercept 
values from calibration graph. 
4.2.1.6.  Quantification of formulation 
  Ten capsules  (Spasmonal containing 120 mg of Alverine Citrate) were 
weighed accurately and the average weight of each capsules was found. The mixed 
contents of the capsule powder equivalent to 40 mg of Alverine Citrate was weighed 
accurately and transferred into 100 ml volumetric flask. Added about 60 ml of      
0.1M Hydrochloric acid to dissolve the substance and the solution was sonicated for 
15 minutes. Then it was made up to the volume to 100 ml with 0.1M Hydrochloric 
acid (400 g/ ml) and centrifuged for 15 minutes. The supernatant liquid was filtered 
through Whatmann filter paper No. 41. From the clear solution, further dilutions were 
made by diluting 3 ml was pipetted out into a series of six 100 ml volumetric flasks 
and made up to the mark with 0.1M Hydrochloric acid to get the concentration of      
12 g/  ml of Alverine Citrate theoretically. The absorbance of six replicates were 
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measured and the amount was calculated by using regression equation. This procedure 
was repeated for six times. 
4.2.1.7. Recovery studies 
4.2.1.7.1.  Preparation of Alverine Citrate raw material stock solution 
 160 mg OF Alverine Citrate was accurately weighed and transferred in to 10 
ml volumetric flask,  sufficient 0.1M Hydrochloric acid was added to dissolve the 
substance and made up to the mark with the same. This solution contains 16 mg/ ml 
concentration.  
4.2.1.7.2.  Recovery procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Alverine Citrate to the pre analyzed formulation. The 
capsule powder equivalent to 40 mg of Alverine Citrate  was weighed accurately and 
added 2 ml, 2.5 ml and 3 ml of above raw material stock solution in to a series of 100 
ml volumetric flasks, dissolved with 0.1M Hydrochloric acid and sonicated for 15 
minutes. The solution was made up to 100 ml with 0.1M Hydrochloric acid and 
centrifuged for 15 minutes at 2000 rpm. The supernatant liquid was filtered through 
Whatmann filter paper No. 41. The absorbance of three replicates was measured at the 
selected wavelength. The amount of drug recovered from formulation was calculated. 
The procedure was repeated for three times for each concentration. 
4.2.1.8.  Validation of developed method  
 4.2.1.8.1.  Linearity 
 A calibration curve was plotted between concentration and absorbance. 
Alverine Citrate was linear with the concentration range of 4– 24 g/ ml at               
207 nm. The optical characteristics were calculated. 
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4.2.1.8.2. Precision 
The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the capsule formulation was calculated. The percentage RSD and were calculated.   
 The intermediate precision of the method was confirmed by intraday and inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time on three successive days. The amount of drug was determined. 
Percentage RSD . 
4.2.1.8.3. Accuracy  
 Accuracy of the method was confirmed by recovery studies. To the pre-
analyzed formulation, a known quantity of raw material of Alverine Citrate  was 
added and the procedure was followed as per the analysis of formulation. The amount 
of each drug recovered was calculated. This procedure was repeated for three times 
for each concentration. The % RSD and confidence  were calculated. 
 4.2.1.8.4. Ruggednes  
Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount was 
calculated. The % RSD and c were calculated. 
4.2.1.8.5. LOD and LOQ 
 The limit of detection (LOD) is the lowest concentration at which the results 
still satisfy some predetermined acceptance criteria. Below the LOD, the results fail to 
meet these criteria (analysis is not feasible).  
It may expessed 
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Where, σ = the standard deviation of the response 
S = the slope of the calibration curve 
 The quantitation limit of an individual analytical procedure is the lowest 
amount of analyte in a sample which can be quantitatively determined with suitable 
precision and accuracy. The quantitation limit is a parameter of quantitative assays for 
low levels of compounds in sample matrices, and is used particularly for the 
determination of impurities and/or degradation products.  
      
   
 
 
Where, σ = the standard deviation of the response 
S = the slope of the calibration curve 
4.2.2. REVERSE PHASE – HPLC METHOD 
            In RP – HPLC, the retention of a compound is determined by its polarity, pKa 
value, molecular weight, experimental conditions, mobile phase, column and 
temperature. The column (typically Octyl (C8) and Octadecyl (C18) bonded phase) is 
less polar than the  water – organic phase, usually an almost or entirely mobile phase. 
Sample molecules partition between the polar mobile phase and non – polar C8 and 
C18 stationary phase and more hydrophobic (non - polar) compounds are retained 
more strongly. Polar compounds are less strongly held and elute from the column first 
and vice versa. Usually, the lower the polarity of the mobile phase higher in its elution 
strength. RP – HPLC columns are efficient, stable and reproducible because of the 
solvents used. Generally gradient and isocratic elution techniques used for elution and 
an isocratic elution technique employed in this study. 
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4.2.2.1.  METHOD DEVELOPMENT AND OPTIMIZATION OF 
CROMATOGRAPHIC CONDITIONS 
4.2.2.2 Selection of mobile phase and  max 
 Solutions of Alverine Citrate 10 g/ ml was prepared in the mobile phase and 
scanned in the UV region of 200 – 400 nm and the UV spectrum was recorded.      It 
was found that the  λ max of Alverine Citrate in mobile phase was 207 nm. Therefore 
207 nm was selected as detection wavelength for the estimation of Alverine Citrate by          
RP – HPLC with an isocratic elution technique. 
4.2.2.3.  Stability of sample solutions 
 Solutions of Alverine Citrate10 g/ ml  were prepared and absorbance was 
checked for their stability at 207 nm and it was found that drug were stable for 5 
hours. 
 4.2.2.3.1.  OPTIMIZATION OF CHROMATOGRAPHIC CONDITIONS 
4.2.2.3.2 . Initial separation conditions 
 The following chromatographic conditions were preset initially to get better 
resolution of Alverine Citrate 
Mode of operation - Isocratic 
Stationary phase - C18 column (150 mm  4.6 mm i.d. 5) 
Mobile phase -        Acetonitrile:Water(HPLC) 
Proportion of mobile phase - 50: 50% v/v 
Detection wavelength -  207 nm 
Flow rate - 1ml/ min 
Temperature - Ambient 
Sample load - 20 l 
Method  - External Standard Calibration method. 
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 The mobile phase was primarily allowed to run for 30 minutes to record a 
steady baseline. The  solution of Alverine Citrate was injected and the respective 
chromatogram was recorded. It was found that Alverine Citrate were eluted  with 
broad peak. For this reason, different ratios of mobile phase with different solvents 
were tried to obtain good chromatogram with acceptable system suitability 
parameters. 
 
 With the above information’s, Acetonitrile: Phosphate buffer and pH adjust 
to 3.5 of  with orthophosphoric acid was selected as mobile phase and further 
optimization was done with this mobile phase. 
S.No Mobile phase Observation 
1 Acetonitrile : Water (50: 50% v/v) Broad peak was obtained 
2 
Acetonitrile: Water pH adjusted to 
3.5 with orthophosphoric acid        
(50: 50% v/v) 
Broad peak with tailing was obtained 
3 
Acetonitrile: Water pH adjusted to 
3.5 with orthophosphoric acid    
(70: 30% v/v) 
Peak splitting was obtained 
4 
Acetonitrile: Water  pH adjusted to 
3.5 with orthophosphoric acid  
(60:40% v/v) 
Peak was sharp but splitting was obtained 
 
4 
Acetonitrile: Phosphate buffer pH 
adjusted to 3.5 with 
orthophosphoric acid 
Sharp peak was obtained 
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4.2.2.3.3  OPTIMIZED OF CHROMATOGRAPHIC CONDITIONS 
 The following optimized chromatographic conditions were employed for the 
analysis of Alverine Citrate by isocratic RP – HPLC method. 
Mode of operation  -  Isocratic 
Stationary phase  -   C18 column (150 mm  4.6 mm i.d. 5) 
Mobile phase                         -  Acetonitrile : Phosphate buffer pH 3.7 adjusted    
                                                 with  orthophosphoric acid . 
Proportion of mobile phase     - 60:40 % v/ v 
Detection wavelength    - 207 nm 
Flow rate   - 1ml/ min 
Temperature   - Ambient 
Sample load   - 20 l 
Operating pressure  - 140kgf 
Method   - External Standard Calibration method. 
 4.2.2.3.2 . Preparation of standard  Alverine Citrate solution 
50 mg of Alverine Citrate was weighed accurately and transferred into 50 ml 
volumetric flask, dissolved in mobile phase and  the volume was made up to the mark 
with  mobile phase. Further, 2.5 ml of mother liquor was pipetted into 25 ml 
volumetric flask and the volume was made with mobile phase to acquire 100 g/ ml 
concentration. 
4.2.2.3.3.  Preparation of Calibration graph 
In this progression, the aliquots of stock solution of Alverine Citrate (1-6 ml) 
was transferred into a series of 10 ml volumetric flasks and made up to the mark with 
mobile phase. The solutions containing the concentrations of 10- 60 g/ ml of 
Alverine Citrate. The  solutions were injected and the chromatograms were recorded. 
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The above concentration range was found to be linear and obeys Beer’s law. The 
procedure was repeated for three times. The peak areas were plotted against 
concentration and the calibration curve was constructed. 
4.2.2.3.4. Estimation of   Alverine Citrate capsule formulation 
  Ten capsules of formulation (Spasmonal containing 120 mg of 
Alverine Citrate) was weighed accurately. The average weight of each capsule was 
found and powdered. The mixed contents of the capsule powder equivalent to  50 mg 
of Alverine Citrate was weighed accurately and transferred into 50 ml volumetric 
flask.  Added about 30 ml of mobile phase to dissolve the substance and made up to 
the volume with the same (1000 g/ ml). The solution was sonicated for 15 minutes, 
centrifuged at 2000 rpm for 15 minutes and filtered through Whatmann filter paper 
No. 41. From the clear solution, further dilutions were made by diluting 2.5 ml into  
25 ml with mobile phase to obtain 100 g/ ml concentration.   
4.2.2.3.5.  Assay Procedure 
        2 ml of test solution was transferred into six 10 ml volumetric flasks 
individually and made up to the mark with mobile phase to obtain 20 g/ ml.             
A steady base line was recorded with optimized chromatographic conditions. After  
stabilization, the test solutions were injected and recorded the chromatograms. The 
concentration of each test solution was determined by using slope and intercept values 
from the calibration graph. 
4.2.2.3.6. Recovery Experiments 
a) Preparation of Alverine Citrate raw material stock solution 
 An accurately weighed quantity of 40 mg of Alverine Citrate was transferred 
into 10 ml volumetric flask and added sufficient mobile phase to dissolve the 
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substance and made up to the mark with the same. This contains 4 mg/ ml 
concentration.  
b) Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Alverine Citrate to the pre analyzed formulation. The 
capsules powder equivalent to 50 mg of  Alverine Citrate was weighed accurately and 
added 2 ml, 2.5 ml, and 3 ml of raw material stock solution into 50 ml standard flasks 
individually and dissolved in mobile phase and made up to the mark with same. The 
solution was sonicated for 15 minutes. After sonication, centrifuged for further          
15 minutes at 2000 rpm and the supernatant liquid was filtered through Whatmann 
filter paper no 41. 2.5 ml of the solution was diluted to 25 ml with mobile phase. 
further, 2 ml of the solution was made up to 10 ml with mobile phase. The solution 
was injected and the chromatograms were recorded. The amount of drug recovered 
was calculated by using slope and intercept valves from the calibration graph.   
LOD and LOQ 
 The linearity study was carried out for three times. The LOD and LOQ were 
calculated based upon the calibration curve method. The LOD and LOQ were 
calculated using the average of slope and standard deviation of intercept. 
System suitability studies 
 The system suitability studies conceded as per ICH guidelines and USP. The 
parameters like tailing factor, asymmetry factor, capacity factor, number of theoretical 
plates and HETP were calculated. 
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5. RESULTS AND DISCUSSION 
 The following methods were developed and validated for the estimation of 
Alverine Citrate in pure and in capsule dosage form. The methods were 
1) UV spectroscopic method 
2) RP-HPLC method 
5.1.  UV SPECTROSCOPIC METHOD  
Alverine Citrate  was identified by using melting point analysis and IR 
spectral studies (figure1). The solubility of Alverine Citrate was determined as per 
Indian Pharmacopoeia. The number of polar and non - polar solvents were tried to 
dissolve the drug. From the solubility data, Alverine Citrate is freely soluble in 
Methanol, Ethanol, ethyl acetate, Dimethyl formamide, Glacial Acetic Acid, alkaline 
borate buffer, isopropyl alcohol, 0.1M Hydrochloric acid and Acetonitrile. It is 
sparingly  soluble in Acetone, Chloroform, phosphate Buffer pH-7 and Dichloro 
methane. Slightly soluble in Diethyl ether and Carbon tetra chloride; very slightly 
soluble in  Distilled water,  Acid Phthalate buffer pH3  and Acid phthalate buffer      
pH 2. Alverine Citrate is practically insoluble in 0.1M Sodium hydrochloride, 
Benzene, Toluene, Neutralized Phthalate buffer pH 5. From the solubility profile 
0.1M Hydrochloric acid  was selected as the solvent  because of it is cheap and easily 
available. The solubility profile of Alverine Citrate is given in table 1.  
The spectrum of Alverine Citrate was recorded in the wavelength range      
200 – 400 nm. From the spectrum, the maximum absorbance was observed at 207 nm. 
Hence 207 nm was selected for the analysis of Alverine Citrate. This is shown      
figure 2. The stability of Alverine Citrate was studied by measuring the absorbance at 
different time intervals. It was observed that the drug was stable up to 5 hours in 0.1M 
Hydrochloride acid.  
  
83 
 
Different aliquots of Alverine Citrate was prepared in the concentration range 
of 4 to 24 μg/ ml. The absorbance of solutions were measured at 207 nm. The 
calibration curve was plotted using concentration against absorbance. The preparation 
of calibration curve was repeated for six times. The optical characteristics like 
Correlation coefficient, Slope, Intercept, Molar Absorptivity, Sandell’s sensitivity, 
LOD and LOQ were calculated. The correlation coefficient value for the calibration 
graph was found to be 0.9995. This indicates that the absorbance was linear with the 
concentration range of 4 – 24 µg/ ml. The calibration curve of Alverine Citrate is 
shown in figure 3. The optical characteristics are listed in table 2.                  
 To confirm the developed method, quantification of raw material was done 
and the amount was calculated. The percentage amount of Alverine Citrate was found 
to be 99.99 ± 0.0734. The amount found by this method was close to 100%. Hence 
this method can be applied for the analysis of formulation. The results are shown in 
table 3. 
Spasmonal capsules was selected for analysis. The nominal concentration of 
Alverine Citrate from the linearity was prepared and the absorbance of the solution 
was measured at 207 nm. The amount of test solution was calculated by using slope 
and intercept values. This procedure was repeated for six times to ensure the precision 
of the method. The percentage label claim in capsules formulation was found to be 
98.25.% ± 1.0034. The amount present in tablet formulation was good concord with 
the label claim and the Percentage Relative Standard Deviation (% RSD) value was 
found to be 1.0213. The low % RSD value indicates that the method has good 
precision. The results of analysis are shown in table 4. 
The intermediate precision of the method was confirmed by intraday and inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
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and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis of Alverine Citrate was found to be 0.7511 and 0.9475, 
respectively. The reports of analysis are shown in tables 5 and 6. The results showed 
that the intermediate precision of the method was confirmed.  
The developed method was validated for Ruggedness. It refers to the analysis 
should be done in same laboratory which may include multiple analysts, multiple 
instruments and different sources of the reagents and so on. . The percentage RSD 
value for analyst 1 and analyst 2 were found to be 0.0734 and 0.2349  respectively. 
The % RSD value for instrument 1 and instrument 2 were found to be 0.0734 and for 
0.5681, respectively. The low % RSD values indicate that the method was more 
rugged. Reports of analysis are shown in tables 7 and 8 for different analyst and 
different instruments, respectively. 
The accuracy of the method was confirmed by recovery studies. To the pre-
analyzed formulation a known quantity of Alverine Citrate raw material solution was 
added at three different concentrations. The concentration of standard raw material 
added were 80%, 100% and 120% of the sample concentration. The absorbance of the 
solutions was measured and the percentage recovery was calculated.  The percentage 
recovery was found to be in the range of 102.56 to 100.20 of Alverine Citrate. The % 
RSD was found to be less than 2. The low % RSD values indicated that there are no 
interferences due to excipients used in formulation during the analysis of Alverine 
Citrate from capsule formulation. Hence the method was found to be accurate. The 
recovery data were shown in table 9. 
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5.22.  RP – HPLC METHOD 
An exertion has been made to simple, precise, rapid, specific and accurate 
method for the estimation of  Alverine citrate in pure form and in formulation by            
RP – HPLC method.   
The solution of 10 g/ ml of Alverine Citrate in mobile phase                        
(Acetonitrile: Phosphate buffer 3.5 adjusted with orthophosphoric acid in the 
proportions of 60: 40% v/v) was prepared and the solution was scanned in the range 
of 200 – 400 nm. At 207 nm the drug showed maximum absorbance. Hence, 207 nm 
was selected as detection wavelength for  the estimation of Alverine Citrate by        
RP – HPLC method with isocratic elution technique and it was found that Alverine 
Citrate was stable up to 5 hours. 
Based up on the properties of the drug, the initial separation was achieved by 
using different mobile phase with different compositions. The mobile phase consists 
of Acetonitrile: Water (50: 50% v/v) was initially tried and chromatograms was 
recorded. This is  shown in figure 4. At 50: 50% v/v ratio, the drug was eluted with 
broad peak. Further Acetonitrile : Water (pH adjusted to 3.5 with orthophosphoric 
acid ) as mobile phase was tried in different ratios. The ratio tried were 50:50% v/v           
60:40% v/v and 70:30% v/v. In all the ratio peak splitting and tailing was occur. 
Hence it was planned to change phosphate buffer instead of water.The chromatograms 
are shown in figure 5, 6 and 7 respectively. Mobile phase consisting of         
Acetonitrile: Phosphate buffer pH adjusted to 3.5 with orthophosphoric acid in the 
ratio of 60:40 v/v was tried. A sharp peak was obtained with marked retention time. 
Hence this was selected as mobile  phase. The optimized chromatogram is shown in 
figure 8. The system suitability parameter were calculated and are shown in table 10. 
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With the optimized chromatographic conditions, stock solutions of Alverine 
Citrate were prepared by using  mobile phase in the concentrations in the range of    
10 - 60 g/ ml. Each solution was injected  and  chromatograms were  recorded. The 
chromatograms are shown in figures 9 - 14. 
 
 The calibration curve was plotted using concentration against peak area. The 
procedure was repeated for three times.  The correlation co-efficient value was found 
to be 0.9999. The calibration graph is shown in figure 15. The optical characteristics 
like correlation coefficient, slope, intercept, LOD, LOQ were calculated and are 
shown in table 11. 
The capsules formulation (spasmonal) was selected for the analysis. The 
nominal concentration (20 g/ ml) from calibration curve was prepared in mobile 
phase. The formulation was injected and the chromatogram was recorded. The 
precision of the method was confirmed by repeatability of formulation for six times 
and chromatograms were recorded as shown in figures 16 - 21. The percentage purity 
of Alverine Citrate present in formulation was found to be 100.06 ± 0.2186                            
The % RSD value was found to be 0.2815. It indicates that the method has good 
precision. The values are shown in table 12. 
The accuracy of the method was performed by recovery studies. To the 
preanalyzed formulation a known quantity of  Alverine  Citrate raw material solution 
was added at three different concentrations (80%, 100% and 120%) and solution were 
injected. The chromatograms were recorded and are shown in the figures 22 - 30. The 
percentage recovery was found to be in the range of 99.91 - 101.69  of  Alverine 
Citrate. The % RSD values were found to be less than 2 for all the concentrations. The 
Low % RSD values indicated that there are no interferences due to the excipients used 
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in formulation during the analysis of alverine citrate from capsules formulation. 
Hence the method was found to be accurate. The recovery data is shown in table 13. 
 
  
 
 
 
 
 
 
 
 
SUMMARY 
AND 
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6. SUMMARY AND CONCLUSION 
A simple, rapid, precise and accurate UV spectrophotometric method and an  
RP-HPLC method were developed and validated for estimation of Alverine Citrate in 
pure form and in  capsule dosage form.  
The methods employed for the analysis of Alverine Citrate were 
1) UV spectroscopic method 
2)  RP-HPLC  method 
6.1.  UV SPECTROSCOPIC METHOD   
From the solubility data the solvent selected for solubility was found to be   
0.1M Hydrochloric acid. The λ max of Alverine Citrate in 0.1M Hydrochloride was   
207 nm. Alverine Citrate was linear with the concentration range of 4- 24 µg/  ml. The 
correlation coefficient value for the calibration graph was found to be 0.9995. The 
percentage of  Alverine Citrate  present in the prepared raw material solution was 
found to be 99.99 ± 0.0734. Spasmonal containing 120 mg of Alverine Citrate were 
selected for analysis. The percentage label claim present in the capsules formulation 
was found to be 98.25 ± 1.0034 of Alverine Citrate. The precision of the method was 
confirmed by the repeated analysis of formulation. The %RSD was found to be 
1.0213. 
Further precision of the method was confirmed by intraday and inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of Alverine 
Citratewas found to be 0.7511 and 0.9475, respectively. The developed method was 
validated for ruggedness. The percentage RSD value by analyst 1 and analyst 2 were 
found to be 0.0734 and 0.2349,  respectively and by instrument 1 and instrument 2 
were found to be 0.0734 and for 0.5681 respectively. The low % RSD values indicate 
that the developed method was more rugged. The accuracy of the method was 
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confirmed by recovery studies. The percentage recovery was found to be in the range 
of  102.56 to 103.20% of Alverine Citrate.  
6.2  RP-HPLC METHOD 
An exertion has been made for a simple, precise, rapid, specific and accurate 
method for the estimation of Alverine Citrate in pure form and in formulation by      
RP – HPLC method.  After optimizing the mobile phase, with the consideration of 
the system suitability parameters, Acetonitrile: phosphate buffer (pH adjusted to 3.5 
with orthophosphoric acid) in the ratio of 60: 40% v/v was selected as mobile phase 
for the analysis.  
With the optimized chromatographic conditions, the drug was linear in the 
concentration range of 10 – 60 g/ ml. the correlation coefficient was found to be 
0.9999. 
 The percentage purity of Alverine citrate present in formulation was found to 
be 100.06 ± 0.2186. The precision of the method was confirmed by repeatability of 
formulation for six times. 
 The accuracy of the method was performed by recovery studies. The 
percentage recovery was found to be in the range of 99.91 to 101.69% of Alverine 
Citrate. The % RSD value was  found to be 08450. It the low % RSD values for 
recovery indicated that the method was found to be accurate. 
           A simple, rapid and accurate UV –  spectroscopy method and an isocratic      
RP – HPLC method were  developed for the determination of Alverine Citrate in bulk 
and in capsule . The methods showed excellent sensitivity, reproducibility, accuracy 
and repeatability, which is evidenced by low percentage relative standard deviation 
values. The results obtained in recovery studies were indicating that there is no 
interference from the excipients used in the formulation. By comparing two methods, 
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UV - spectroscopy method was found to be economic when compared to RP - HPLC. 
Because the solvents and column used in RP - HPLC are very costly. When 
comparing the sensitivity of the methods, RP - HPLC method was found to be more 
sensitive than UV - spectroscopy method. Because the linearity range, LOD and LOQ 
were less in RP - HPLC method than UV – spectroscopic  method. Hence it is 
suggested that the proposed UV spectroscopic methods and RP - HPLC method can 
be effectively applied for the routine quality control analysis of Alverine Citrate in 
bulk and in capsule formulation.  
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FIGURE – 1 
IR SPECTRUM OF ALVERINE CITRATE 
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FIGURE – 2 
UV SPECTRUM OF ALVERINE CITRATE IN                                           
0.1M HYDRO CHLORIC ACID(10 µg/ ml) 
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FIGURE – 3 
CALIBRATION CURVE OF ALVERINE CITRATE IN             
0.1M HYDRO CHLORIC ACID AT 207 nm BY UV 
SPECTROSCOPY 
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FIGURE – 4 
INITIAL SEPERATION CONDITIONS                                   
ACETONITRILE: WATER (50:50% v/v) 
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 FIGURE-5  
INITIAL SEPERATION CONDITIONS                                   
ACETONITRILE: WATER pH 3.5 (50:50% v/v) 
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FIGURE - 6 
INITIAL SEPERATION CONDITIONS                                      
ACETONITRILE: WATER PH 3.5 (60:40% v/v) 
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FIGURE - 7 
INITIAL SEPERATION CONDITIONS  ACETONITRILE: 
WATER PH 3.5 (70:30% v/v) 
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FIGURE-8 
 OPTIMIZED CHROMATOGRAM 
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FIGURE – 9 
LINEARITY CHROMATOGRAM OF ALVERINE CITRATE 
 
(10µg/ ml) 
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  FIGURE – 10 
LINEARITY CHROMATOGRAM OFALVERINE CITRATE       
(20 µg/ml)  
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FIGURE –11                                                                                                     
LINEARITY CHROMATOGRAM OF ALVERINE CITRATE     
(30 µg/ ml)  
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                                                     FIGURE – 12 
LINEARITY CHROMATOGRAM OF ALVERINE CITRATE     
(40 µg/ ml) 
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FIGURE – 13 
LINEARITY CHROMATOGRAM OF ALVERINE CITRATE      
(50 µg/ ml) 
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FIGURE – 14 
LINEARITY CHROMATOGRAM OF ALVERINE CITRATE      
(60 µg/ ml) 
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FIGURE – 15 
CALIBRATION CURVE OF ALVERINE CITRATE BY RP-HPLC 
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FIGURE – 16 
REPEATABILITY ANALYSIS OF FORMULATION - 1                
BY RP- HPLC 
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 FIGURE –17 
REPEATABILITY ANALYSIS OF FORMULATION - 2                
BY RP- HPLC 
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FIGURE – 18 
REPEATABILITY ANALYSIS OF FORMULATION - 3               
BY RP- HPLC 
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                                                 FIGURE – 19 
REPEATABILITY ANALYSIS OF FORMULATION - 4                
BY RP- HPLC 
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FIGURE-20 
REPEATABILITY ANALYSIS OF FORMULATION - 5                
BY RP- HPLC 
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FIGURE – 21                                                                    
REPEATABILITY ANALYSIS OF FORMULATION - 6                
BY RP- HPLC 
 
 
  
112 
 
                                                        FIGURE –22 
CHROMATOGRAM FOR RECOVERY ANALYSIS-1               
(80%) 
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FIGURE – 23 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 2               
(80%) 
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                                            FIGURE – 24 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 3               
(80%) 
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FIGURE – 25 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 1               
(100%) 
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FIGURE –26 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 2               
(100%) 
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                                               FIGURE – 27 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 3               
(100%) 
 
 
 
  
118 
 
FIGURE-28 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 1 
(120%) 
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FIGURE – 29 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 2 
(120%) 
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 FIGURE – 30 
CHROMATOGRAM FOR RECOVERY ANALYSIS - 3 
(120%) 
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                                          TABLE – 1 
SOLUBILITY PROFILE OF ALVERINE  CITRATE IN POLAR 
AND NON-POLAR SOLVENTS 
S. 
No 
SOLVENTS 
EXTENT OF 
SOLUBILITY 
CATEGORY 
1. Distilled water 10 mg in  20ml Very slightly soluble 
2. Methanol 10 mg in 18µl Freely soluble 
3. Ethanol 10 mg in 16  µl Freely  soluble 
4. Acetonitrile 10 mg in 30 µl Freely soluble 
5. Di methyl Formamide 10 mg in 16µl Freely soluble 
6. Acetone 10 mg in 8µl Freely  soluble 
7. Glacial Acetic acid 10 mg in 17 µl Freely soluble 
8. Ethyl acetate 10 mg in 16 µl Freely soluble 
9. Chloroform 10 mg in 24 µl Freely soluble 
10. Diethyl ether 10 mg in 25 ml Slightly soluble 
11. 0.1M Hydrochloric Acid 10 mg in 17µl Freely soluble 
12. 0.1M Sodium Hydroxide 
10 mg in more than        
100 ml 
Practically insoluble 
soluble 
13. Phosphate Buffer pH 7 10 mg in 350 µl Sparingly soluble 
14 Iso propyl alcohol 10 mg in 24 µl Freely soluble 
15 Carbon tetra chloride 10 mg in 6ml Slightly soluble 
17 Benzene 
10 mg in more than    
100 ml 
Practically insoluble 
18 Toluene 
10 mg in more than    
100 ml 
Practically insoluble 
19 
Acid Phthalate Buffer 
(pH3) 
10 mg in 90 ml 
 
Very slightly soluble 
 
  
122 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
Acid Phthalate Buffer  
(pH 2.2) 
10 mg in 50ml Very slightly soluble 
21 
Neutralized Phthalate 
Buffer (pH5) 
10 mg in more than    
100 ml 
Practically insoluble 
22 Alkaline Borate Buffer 10 mg in16 µl Freely soluble 
23 Dichloride methane 10mg in 1 ml Sparingly soluble 
24 Diethyl ether 10 mg in 25 ml Slightly soluble 
25 Phosphate buffer 10 mg in 350  µl Sparingly soluble 
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                                                   TABLE – 2 
OPTICAL CHARACTERISTICS OF ALVERINE  CITRATE  
BY UV METHOD 
 
 *Mean of six observations
PARAMETERS VALUES* 
max (nm) 207 
Beer’s law limit (g/ ml) 4-24 
Sandell’s sensitivity 
(g/cm2/0.001 A.U) 
0.0295 
Molar absorptivity 
(L mol
–1
 cm
–1
) 
1.6204 x 10 
- 4 
Correlation coefficient (r) 0.9995 
Regression equation 
(Y= mx+c) 
Y = 0.0339x+ 0.0029 
Slope(m) 0.0339 
Intercept(c) 0.0029 
LOD (g/ ml) 0.0632 
LOQ (g/ ml) 0.1915 
Standard error 
 
0.0103 
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TABLE - 3 
QUANTIFICATION OF RAW MATERIAL BY 
UV METHOD 
 
               *Mean of six observations 
 
 
 
 
 
 
 
 
 
 
 
 
S. No 
Amount 
found 
(µg/ml)* 
Percentage 
Obtained* 
(%) 
Mean 
(%) 
SD %RSD SE 
 
1. 
 
11.9933 
 
 
99.99 
  
 
 
 
 
100.12 
 
 
 
 
 
0.0734 
 
0.0734 
 
0.0020 
 
2 . 
 
11.9964 
99.97 
 
 
3. 
 
12.0141 
100.12 
 
 
4. 
11.9993 
99.99 
 
 
5. 
 
11.9905 
99.92 
 
 
6. 
  11.9905 99.92 
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TABLE - 4 
QUANTIFICATION OF FORMULATION 
BY UV METHOD 
 
*Mean of six observations 
 
 
 
 
 
 
 
 
 
 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
Obtained* 
%(w/v) 
% Mean 
 
SD 
% 
RSD 
SE CI 
 
120.0000 
 
 
119.5180 
 
99.60 
 
 
 
 
 
 
98.25 
 
 
 
 
 
 
 
 
 
1.0034 
 
 
 
 
 
1.0213 
 
 
 
 
 
0.02789 
 
 
 
 
 
96.60 
to 
99.90 
 
 
 
 
 
120.0000 
 
 
117.1350 
97.61 
 
120.0000 
 
 
116.4580 
97.05 
 
120.0000 
 
 
117.4850 
97.90 
 
120.0000 
 
 
117.3380 
97.78 
 
120.0000 119.1980 
 
99.33 
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TABLE - 5 
INTRADAY ANALYSIS OF FORMULATION 
BY UV METHOD 
 
         * Mean of three observations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
 
Percentage 
Obtained* 
 
Mean 
(%) 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
 
120.0000 
 
 
 
117.4890 
 
 
 
97.91 
 
 
 
 
 
99.98 
 
 
 
 
0.7434 
 
 
 
 
0.7511 
 
 
 
 
 
 
0.0465 
 
 
           
97.76  
to 
100.20  
120.0000 
 
 
 
119.5220 
 
 
 
99.60 
 
 
 
120.0000 
 
 
 
118.1670 
 
99.06 
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TABLE - 6 
INTERDAY ANALYSIS OF FORMULATION   
BY UV METHOD 
 
             *Mean of three observations 
 
 
 
 
 
 
 
 
 
 
 
 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
 
Percentage 
Obtained* 
 
Mean 
(%) 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
 
120.0000 
 
120.2880 
 
100.24 
 
 
 
 
99.54 
 
 
 
 
0.9432 
 
 
 
 
0.9475 
 
 
 
 
 
 
0.1048 
 
 
 
97.99 
to 
101.09 
 
 
120.0000 
  
119.9050 
 
99.92 
120.000 118.1670 98.47 
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TABLE – 7 
RUGGEDNESS STUDY BY UV METHOD 
(DIFFERENT ANALYSTS) 
 
*Mean of six observation 
                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Condition 
Labeled 
Amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
 
Percentage 
Obtained* 
 
Mean 
(%) 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
 
Analyst 1 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
119.9938 
119.9643 
120.1410 
119.9938 
119.9050 
119.9050 
99.99 
99.97 
100.12 
99.99 
99.92 
99.92 
 
 
99.99 
 
 
0.0734 
 
 
0.0734 
 
 
0.0020 
 
99.87  
to 
100.11 
Analyst 2 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
121.4670 
120.2589 
120.5241 
120.1411 
119.8170 
119.9348 
100.39 
100.22 
100.44 
100.12 
99.85 
99.95 
 
 
100.16 
 
 
0.2352 
 
 
0.2349 
 
 
0.0065 
 
99.77 
to 
100.55 
 
  
129 
 
 
                                                     
TABLE – 8 
RUGGEDNESS STUDY BY UV METHOD 
(DIFFERENT INSTRUMENTS) 
 
 
*Mean of six observations 
 
 
 
 
 
 
 
                                                         
 
 
 
Condition 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
 
Mean 
(%) 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
 
 
 
Instrument I 
 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
 
119.9938 
119.9643 
120.1410 
119.9938 
119.9050 
119.9050 
 
99.99 
99.97 
100.12 
99.99 
99.92 
99.92 
 
 
 
98.25 
 
 
 
0.0734 
 
 
 
0.0734 
 
 
 
0.0020 
 
 
99.87 
to 
 
100.11 
 
 
 
Instrument II 
 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
120.0000 
 
121.4670 
120.2589 
120.3149 
121.4928 
120.1116 
119.9938 
 
101.22 
100.22 
100.26 
101.24 
100.09 
99.99 
 
 
 
100.50 
 
 
 
0.5710 
 
 
 
0.5681 
 
 
 
0.0159 
 
 
99.50 
to 
101.44 
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TABLE – 9 
RECOVERY ANALYSIS OF FORMULATION 
BY UV METHOD 
 
 
 
*Mean of three observations
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount 
found* 
(µg/ml) 
Amount  
recovered  
(µg/ml) 
 
% 
Recovery 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
9.7278 
9.7278 
9.7278 
8.0000 
8.0000 
8.0000 
17.9841 
17.9598 
17.9657 
8.2563 
8.2320 
8.2379 
103.20 
102.90 
102.97 
 
 
 
 
0.2251 
 
 
 
 
0.2188 
 
 
 
 
0.0028 
 
 
 
102.59 
to 
103.09 
9.7278 
9.7278 
9.7278 
10.0000 
10.0000 
10.0000 
20.0341 
20.0194 
20.0076 
10.3063 
10.2916 
10.2798 
103.06 
102.92 
102.80 
9.7278 
9.7278 
9.7278 
12.0000 
12.0000 
12.0000 
22.0376 
22.0406 
22..0347 
12.3098 
12.3128 
12.3069 
102.58 
102.61 
102.56 
Mean 102.84 
  
 
TABLE – 10 
SYSTEM SUITABILITY PARAMETERS FOR THE OPTIMIZED 
CHROMATOGRAM BY RP – HPLC METHOD 
 
PARAMETERS VALUES STANDARD LIMIT 
Retention time 3.143 ---- 
Tailing factor 1.499 < 2 
Asymmetrical factor 1.424 < 2 
Number of Theoretical plates 6126 >2000 
HETP 24.487 ---- 
Capacity factor 1.03 >1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
TABLE – 11 
OPTICAL CHARACTERISTICS OF ALVERINE CITRATE BY            
RP-HPLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Mean of three observations 
 
 
 
 
 
 
 
PARAMETERS VALUES* 
Detection wavelength (nm) 207 
Beer’s law limit (µg/ml) 10 – 60 
Correlation coefficient (r) 0.9999 
Regressionequation 
(Y = mx + c) 
Y = 18218.0726+ (-2465.75) 
Slope (m) 18218.726 
Intercept (c)s -2465.75 
LOD (ng/ µl) 0.0670 
LOQ (ng/ µl) 0.2031 
Standard error 
 
4435.1146 
  
 
TABLE – 12 
ANALYSIS OF FORMULATION BY RP- HPLC METHOD 
 
  *Mean of six observations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                             
 
 
 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
 
Percentage 
Obtained* 
 
Mean 
(%) 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
120.0000 119.8561 99.88 
100.06 0.2186 0.2185 0.0061 
99.70  
to   
100.42 
 
120.0000 
     
120.0577 100.01 
120.0000 120.2900 100.24 
120.0000 119.8993 99.92 
120.0000 120.5086 100.42 
120.0000 119.8928 99.91      
  
 
 
 
 
 
 
 
 
TABLE –13 
RECOVERY ANALYSIS OF FORMULATION 
BY RP-HPLC METHOD 
*Mean of three observations 
 
 
 
Amount 
present 
(µg/ml) 
Amount 
added 
(µg/ml) 
Amount 
found* 
(µg/ml) 
Amount  
recovered  
(µg/ml) 
 
% 
Recovery 
 
SD 
 
% 
RSD 
 
SE 
 
CI 
20.0066 
20.0066 
20.0066 
16.0000 
16.0000 
16.0000 
36.2274 
36.1611 
35.9924 
16.2208 
16.1551 
15.9858 
101.38 
100.96 
99.91 
 
 
 
 
0.5736 
 
 
 
 
0.5697 
 
 
 
 
0.0071 
 
 
 
100.05 
to 
101.33 
 
 
 
 
20.0066 
20.0066 
20.0066 
20.0000 
20.0000 
20.0000 
40.3452 
40.0547 
40.1701 
20.3386 
20.0481 
20.1641 
101.69 
100.24 
100.82 
20.0066 
20.0066 
20.0066 
24.0000 
24.0000
24.0000 
44.1258 
44.0789 
44.1100 
24.1192 
24.0723 
24.1034 
100.50 
100.30 
100.43 
Mean 100.69 
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